PAR-21-226 |
See Related
|
ORIP |
04/30/2021 |
08/05/2021
|
09/06/2024
|
R41/R42
|
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R41/R42 Clinical Trial Not Allowed) |
PAR-21-225 |
See Related
|
ORIP |
04/30/2021 |
08/06/2021
|
09/06/2024
|
R43/R44
|
Novel Tools and Devices for Animal Research Facilities and to Support Care of Animal Models (R43/R44 Clinical Trial Not Allowed) |
PAR-21-227 |
See Related
|
NIGMS |
04/27/2021 |
08/24/2021
|
09/25/2021
|
U24
|
Resource Center for the Support for Research Excellence (SuRE) Program (U24 - Clinical Trial Not Allowed) |
PAR-21-234 |
See Related
|
NINDS |
04/23/2021 |
05/12/2021
|
05/08/2024
|
K01
|
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed) |
PAR-21-233 |
See Related
|
NINDS |
04/23/2021 |
07/10/2021
|
04/06/2024
|
U44
|
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
PA-21-231 |
See Related
|
NICHD |
04/21/2021 |
05/16/2021
|
05/08/2024
|
R03
|
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required) |
PA-21-221 |
See Related
|
NICHD |
04/21/2021 |
05/16/2021
|
05/08/2024
|
R03
|
NICHD Small Research Grant Program (R03 Clinical Trial Required) |
PAR-21-209 |
See Related
|
NINDS |
04/19/2021 |
06/27/2021
|
07/28/2021
|
R21
|
NIH Countermeasures Against Chemical Threats (CounterACT) Early-stage Investigator Research Award (R21 Clinical Trial Not Allowed) |
PAS-21-216 |
See Related
|
NIMH |
04/16/2021 |
09/05/2021
|
10/06/2021
|
R01
|
Identification of Positive Valence System Related Targets for Novel Suicide Prevention Approaches (R01 - Clinical Trial Optional) |
PAS-21-215 |
See Related
|
NIMH |
04/16/2021 |
09/16/2021
|
10/17/2021
|
R21
|
Identification of Positive Valence System Related Targets for Novel Suicide Prevention Approaches (R21 Clinical Trial Optional) |
PAR-21-186 |
See Related
|
NIDCD |
04/15/2021 |
04/28/2021
|
01/30/2024
|
R25
|
Enhancing NIDCD's Extramural Workforce Diversity through Research Experiences (R25 Clinical Trial Not Allowed) |
PAR-21-159 |
See Related
|
ORIP |
04/12/2021 |
12/06/2021
|
01/07/2022
|
C06
|
Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed) |
PAR-21-198 |
See Related
|
NIGMS |
04/08/2021 |
08/28/2021
|
09/28/2023
|
T32
|
National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32) |
PAR-21-153 |
See Related
|
NINDS |
04/08/2021 |
05/12/2021
|
05/08/2024
|
K01
|
NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Clinical Trial Required) |
PAR-21-213 |
See Related
|
NIA |
04/06/2021 |
05/09/2021
|
11/09/2021
|
U01
|
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) |
PAR-21-203 |
See Related
|
NCATS |
04/06/2021 |
05/21/2021
|
06/22/2023
|
U24
|
Limited Competition: Clinical and Translational Science Awards (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (U24 Clinical Trials Not Allowed) |
PAR-21-207 |
See Related
|
NIA |
04/06/2021 |
08/15/2021
|
01/27/2022
|
R01
|
Mechanism-Focused Research to Promote Adherence to Healthful Behaviors to Prevent Mild Cognitive Impairment (MCI) and Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Optional) |
PAR-21-181 |
See Related
|
NINDS |
04/05/2021 |
04/25/2021
|
05/08/2024
|
P01
|
NINDS Program Project Grant (P01 Clinical Trial Optional) |
PAR-21-188 |
See Related
|
NIDCD |
04/05/2021 |
04/28/2021
|
01/30/2024
|
R25
|
Research Experiences to Enhance Clinician-Scientists' Participation in NIDCDs Research (R25 Clinical Trial Not Allowed) |
PA-21-214 |
See Related
|
NHGRI |
04/01/2021 |
05/12/2021
|
02/13/2023
|
K18
|
Short-Term Mentored Research Career Enhancement Award to Promote Diversity (K18 No Independent Clinical Trials) |
PAR-21-197 |
See Related
|
NIDCR |
04/01/2021 |
05/08/2021
|
05/08/2024
|
UG3/UH3
|
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
PAR-21-211 |
See Related
|
NIMH |
04/01/2021 |
05/16/2021
|
03/17/2024
|
R34
|
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required) |
PAR-21-210 |
See Related
|
NIMH |
04/01/2021 |
05/05/2021
|
03/06/2024
|
R01
|
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) |
PAR-21-185 |
See Related
|
NIDCD |
04/01/2021 |
04/28/2021
|
01/30/2024
|
R25
|
Mentoring Networks to Enhance Diversity in NIDCD's Extramural Research Workforce (R25 Clinical Trial Not Allowed) |
PAR-21-196 |
See Related
|
NIGMS |
03/31/2021 |
09/14/2021
|
10/14/2023
|
R25
|
Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed) |
PA-21-201 |
See Related
|
NIMH |
03/31/2021 |
05/05/2021
|
03/06/2024
|
R01
|
Research on Autism Spectrum Disorders (R01 Clinical Trial Optional) |
PA-21-200 |
See Related
|
NIMH |
03/31/2021 |
05/16/2021
|
03/17/2024
|
R21
|
Research on Autism Spectrum Disorders (R21 Clinical Trial Optional) |
PA-21-199 |
See Related
|
NIMH |
03/31/2021 |
05/16/2021
|
03/17/2024
|
R03
|
Research on Autism Spectrum Disorders (R03 Clinical Trial Optional) |
PAR-21-187 |
See Related
|
NIDCD |
03/31/2021 |
04/28/2021
|
01/30/2024
|
R25
|
NIDCD's Mentoring Networks to Enhance Clinician-Scientists' Participation in Research (R25 Clinical Trial Not Allowed) |
PAR-21-208 |
See Related
|
NIDA |
03/26/2021 |
07/10/2021
|
03/09/2024
|
R21
|
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) |
PAR-21-166 |
See Related
|
NCI |
03/25/2021 |
05/05/2021
|
01/08/2024
|
R01
|
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) |
PAR-21-206 |
See Related
|
NCI |
03/25/2021 |
05/05/2021
|
01/08/2024
|
R01
|
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) |
PAR-21-143 |
See Related
|
NHGRI |
03/25/2021 |
07/08/2021
|
04/09/2024
|
F99/K00
|
NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00) |
PAR-21-183 |
See Related
|
NIDA |
03/23/2021 |
07/04/2021
|
12/07/2023
|
UG3/UH3
|
Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) |
PAR-21-212 |
See Related
|
NIA |
03/23/2021 |
05/05/2021
|
05/08/2024
|
U01
|
Limited Competition: Alzheimers Disease Sequencing Project Follow-Up Study 2.0 (ADSP FUS 2.0): The Diverse Population Initiative (U01 Clinical Trial Not Allowed) |
PAR-21-176 |
See Related
|
NIMH |
03/18/2021 |
05/14/2021
|
05/08/2024
|
R21
|
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R21 Clinical Trial Optional) |
PAR-21-175 |
See Related
|
NIMH |
03/18/2021 |
05/05/2021
|
05/08/2024
|
R01
|
Understanding and Modifying Temporal Dynamics of Coordinated Neural Activity (R01 Clinical Trial Optional) |
PAR-21-184 |
See Related
|
NIAID |
03/18/2021 |
06/16/2021
|
03/16/2022
|
R21
|
Research on Bat Immunology (R21 Clinical Trial Not Allowed) |
PAR-21-169 |
See Related
|
NIGMS |
03/18/2021 |
04/26/2021
|
09/08/2023
|
R16
|
Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) |
PAR-21-173 |
See Related
|
NIGMS |
03/18/2021 |
08/28/2021
|
01/08/2024
|
R16
|
Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed) |
PAR-21-061 |
See Related
|
NCI |
03/18/2021 |
05/15/2021
|
11/18/2023
|
R21
|
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) |
PAR-21-167 |
See Related
|
ORIP |
03/17/2021 |
05/16/2021
|
05/08/2024
|
R21
|
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) |
PA-21-194 |
See Related
|
NIMH |
03/16/2021 |
05/12/2021
|
05/08/2024
|
K22
|
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed) |
PA-21-195 |
See Related
|
NIMH |
03/16/2021 |
05/12/2021
|
05/08/2024
|
K22
|
Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required) |
PAR-21-111 |
See Related
|
NCI |
03/15/2021 |
05/12/2021
|
03/15/2024
|
K22
|
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) |
PAR-21-128 |
See Related
|
NCI |
03/15/2021 |
05/12/2021
|
03/15/2024
|
K22
|
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) |
PAR-21-318 |
See Related
|
NCI |
03/15/2021 |
05/12/2021
|
03/15/2024
|
K22
|
The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) |
PAR-21-171 |
See Related
|
NIEHS |
03/15/2021 |
05/12/2021
|
05/08/2024
|
K01
|
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Required) |
PAR-21-172 |
See Related
|
NIEHS |
03/15/2021 |
05/12/2021
|
05/08/2024
|
K01
|
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Clinical Trial Not Allowed) |
PAR-21-170 |
See Related
|
NIEHS |
03/15/2021 |
05/12/2021
|
05/08/2024
|
K01
|
Transition to Independent Environmental Health Research (TIEHR) Career Award (K01 Independent Basic Experimental Studies with Humans Required) |
PAR-21-189 |
See Related
|
NIGMS |
03/15/2021 |
04/25/2021
|
01/26/2024
|
T32
|
Medical Scientist Training Program (T32) |
PAR-21-190 |
See Related
|
NCI |
03/12/2021 |
10/08/2021
|
03/08/2024
|
R01
|
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
PAR-21-122 |
See Related
|
NINDS |
03/12/2021 |
05/17/2021
|
02/21/2024
|
R61/R33
|
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) |
PAR-21-123 |
See Related
|
NINDS |
03/12/2021 |
05/17/2021
|
02/21/2024
|
R61/R33
|
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed) |
PAR-21-124 |
See Related
|
NINDS |
03/12/2021 |
05/17/2021
|
02/21/2024
|
R61/R33
|
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) |
PA-21-202 |
See Related
|
AHRQ |
03/11/2021 |
03/17/2021
|
06/19/2023
|
R03
|
AHRQ/PCORI Learning Health System Small Grant Pilot Program |
PAR-21-163 |
See Related
|
NINDS |
03/11/2021 |
07/10/2021
|
05/08/2024
|
UG3/UH3
|
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
PAS-21-150 |
See Related
|
NIDDK |
03/08/2021 |
05/05/2021
|
05/08/2024
|
R01
|
New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional) |
PAR-21-193 |
See Related
|
NIOSH |
03/05/2021 |
03/12/2021
|
12/15/2025
|
U13
|
NIOSH Support for Conferences and Scientific Meetings (U13 Clinical Trial Not Allowed) |
PAR-21-141 |
See Related
|
NIA |
03/04/2021 |
04/25/2021
|
09/08/2023
|
R25
|
AD/ADRD Clinical Trials Short Course (R25 Independent Clinical Trial Not Allowed) |
PAR-21-160 |
See Related
|
NIDCR |
03/04/2021 |
05/08/2021
|
05/08/2024
|
UG3/UH3
|
NIDCR Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) |
PAR-21-137 |
See Related
|
NIMH |
03/02/2021 |
05/15/2021
|
02/16/2024
|
R61/R33
|
Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required) |
PAR-21-136 |
See Related
|
NIMH |
03/02/2021 |
05/15/2021
|
02/16/2024
|
R33
|
Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required) |
PAR-21-135 |
See Related
|
NIMH |
03/02/2021 |
05/15/2021
|
02/16/2024
|
R61/R33
|
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required) |
PAR-21-129 |
See Related
|
NIMH |
03/02/2021 |
05/15/2021
|
02/16/2024
|
R01
|
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01 Clinical Trial Required) |
PAR-21-132 |
See Related
|
NIMH |
03/02/2021 |
05/15/2021
|
02/16/2024
|
R01
|
Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required) |
PAR-21-134 |
See Related
|
NIMH |
03/02/2021 |
05/15/2021
|
02/16/2024
|
R33
|
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required) |
PAR-21-130 |
See Related
|
NIMH |
03/02/2021 |
05/15/2021
|
02/16/2024
|
R01
|
Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required) |
PAR-21-131 |
See Related
|
NIMH |
03/02/2021 |
05/15/2021
|
02/16/2024
|
R34
|
Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 Clinical Trial Required) |
PAR-21-133 |
See Related
|
NIMH |
03/02/2021 |
05/15/2021
|
02/16/2024
|
U01
|
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Devices for Psychiatric Disorders (U01 Clinical Trial Required) |
PAR-21-156 |
See Related
|
NIA |
02/26/2021 |
03/26/2021
|
11/19/2021
|
U19
|
The Midlife in the United States Study (U19 Clinical Trial Not Allowed) |
PAR-21-157 |
See Related
|
NIA |
02/26/2021 |
03/26/2021
|
11/19/2021
|
U01
|
The Midlife in the United States Study - Cognitive and Neurocognitive Precursors of AD/ADRD (U01 Clinical Trial Not Allowed) |
PAR-21-149 |
See Related
|
NINDS |
02/24/2021 |
04/25/2021
|
05/26/2023
|
T32
|
NINDS Institutional Research Training Program (T32 - Clinical Trial Not Allowed) |
PAR-21-147 |
See Related
|
NIGMS |
02/23/2021 |
04/26/2021
|
05/27/2023
|
T34
|
Maximizing Access to Research Careers (T34 - Clinical Trial Not Allowed) |
PAR-21-146 |
See Related
|
NIGMS |
02/18/2021 |
04/26/2021
|
05/27/2023
|
T34
|
Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34 - Clinical Trial Not Allowed) |
PAR-21-179 |
See Related
|
FDA |
02/18/2021 |
05/28/2021
|
02/03/2024
|
R01
|
Minor Use Minor Species Development of Drugs (R01) |
PAR-21-178 |
See Related
|
FDA |
02/18/2021 |
02/24/2021
|
05/04/2023
|
U01
|
Drug Development Tools Research Grants (U01) Clinical Trial Optional |
PAR-21-174 |
See Related
|
FDA |
02/17/2021 |
02/22/2021
|
03/02/2023
|
U2F
|
The FDA's Cooperative Agreement Program for States and Territories to Implement a National Produce Safety Program (U2F) Clinical Trials Not Allowed |
PAR-21-120 |
See Related
|
FIC |
02/17/2021 |
07/03/2021
|
08/04/2023
|
D43
|
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) |
PAR-21-165 |
See Related
|
NIOSH |
02/10/2021 |
04/01/2021
|
10/01/2022
|
U60
|
Underground Mine Evacuation Technologies and Human Factors Research (U60) |
PA-21-151 |
See Related
|
NIH |
02/10/2021 |
03/12/2021
|
01/08/2024
|
R13
|
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
PA-21-164 |
See Related
|
AHRQ |
02/09/2021 |
02/09/2021
|
07/18/2024
|
R21/R33
|
Using Innovative Digital Healthcare Solutions to Improve Quality at the Point of Care (R21/R33 - Clinical Trial Optional) |
PAR-20-319 |
See Related
|
NEI |
02/09/2021 |
03/13/2021
|
04/14/2023
|
R24
|
NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional) |
PAR-21-060 |
See Related
|
NIDCR |
02/08/2021 |
03/08/2021
|
01/08/2024
|
F99/K00
|
NIDCR Predoctoral to Postdoctoral Transition Award for a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed) |
PAR-21-127 |
See Related
|
ORIP |
02/08/2021 |
05/01/2021
|
06/02/2021
|
S10
|
Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed) |
PAR-21-126 |
See Related
|
ORIP |
02/08/2021 |
05/01/2021
|
06/02/2021
|
S10
|
High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed) |
PAR-21-125 |
See Related
|
ORIP |
02/08/2021 |
05/01/2021
|
06/02/2021
|
S10
|
Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed) |
PAR-21-115 |
See Related
|
NICHD |
02/08/2021 |
01/05/2021
|
01/08/2024
|
R01
|
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) |
PAR-21-116 |
See Related
|
NCCIH |
02/01/2021 |
02/15/2021
|
09/28/2023
|
U24
|
Limited Competition for the Continuation of Multisite Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Optional) |
PAR-21-117 |
See Related
|
NCCIH |
02/01/2021 |
02/15/2021
|
09/28/2023
|
UG3/UH3
|
Limited Competition for the Continuation or Revision of Multisite Clinical Trial Clinical Coordinating Center (Collaborative UH3 Clinical Trial Optional) |
PAR-20-317 |
See Related
|
NIA |
01/26/2021 |
04/25/2021
|
05/26/2023
|
R25
|
NIA MSTEM: Advancing Diversity in Aging Research through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed) |
PAR-21-106 |
See Related
|
NIA |
01/25/2021 |
05/12/2021
|
05/08/2024
|
K07
|
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) |
PAR-21-114 |
See Related
|
NINDS |
01/25/2021 |
03/05/2021
|
01/06/2024
|
R44
|
NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed) |
PAR-21-112 |
See Related
|
NIA |
01/22/2021 |
04/25/2021
|
09/26/2023
|
T32
|
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (T32) |
PAR-21-096 |
See Related
|
NIDCD |
01/19/2021 |
01/08/2021
|
01/08/2024
|
K18
|
NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required) |
PAR-21-095 |
See Related
|
NIDCD |
01/19/2021 |
01/08/2021
|
01/08/2024
|
K18
|
NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Clinical Trial Not Allowed) |
PAR-21-094 |
See Related
|
NIDCD |
01/19/2021 |
01/08/2021
|
01/08/2024
|
K18
|
NIDCD Research Career Enhancement Award for Established Investigators (K18 Clinical Trial Required) |
PAR-21-118 |
See Related
|
NHLBI |
01/15/2021 |
05/04/2021
|
01/08/2024
|
R33
|
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required) |
PAR-21-119 |
See Related
|
NHLBI |
01/15/2021 |
05/04/2021
|
01/08/2024
|
R61/R33
|
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33 Clinical Trial Required) |
PAR-21-083 |
See Related
|
NIAID |
01/14/2021 |
02/12/2021
|
01/14/2024
|
U01
|
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) |
PAR-21-082 |
See Related
|
NIAID |
01/14/2021 |
04/14/2021
|
01/14/2024
|
U44
|
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) |
PAR-21-108 |
See Related
|
NIDCR |
01/14/2021 |
03/08/2021
|
01/08/2024
|
F99/K00
|
NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed) |
PAR-21-148 |
See Related
|
NIOSH |
01/13/2021 |
03/12/2021
|
12/15/2025
|
R13
|
NIOSH Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) |
PA-21-110 |
See Related
|
NIDA |
01/13/2021 |
01/16/2021
|
05/08/2024
|
R34
|
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) |
PAR-21-109 |
See Related
|
NIA |
01/11/2021 |
05/16/2021
|
05/08/2024
|
R21
|
Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) |
PAR-21-062 |
See Related
|
NIDDK |
01/11/2021 |
04/07/2021
|
01/08/2024
|
R21
|
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of the NIDDK (R21 Clinical Trial Not Allowed) |
PAR-21-089 |
See Related
|
ORIP |
01/08/2021 |
04/07/2021
|
01/08/2024
|
U42
|
Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed) |
PAS-21-031 |
See Related
|
NIDDK |
01/08/2021 |
04/07/2021
|
01/08/2024
|
R01
|
Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Optional) |
PAR-21-121 |
See Related
|
NCATS |
01/04/2021 |
02/26/2021
|
10/18/2023
|
R03
|
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional) |
PAR-21-105 |
See Related
|
FIC |
01/04/2021 |
02/09/2021
|
03/09/2023
|
K01
|
International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required) |
PAR-21-104 |
See Related
|
FIC |
01/04/2021 |
02/09/2021
|
03/09/2023
|
K01
|
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed |
PAR-21-100 |
See Related
|
NINDS |
12/23/2020 |
01/05/2021
|
02/06/2023
|
R01
|
Music and Health: Understanding And Developing Music Medicine (R01 Clinical Trial Optional) |
PAR-21-099 |
See Related
|
NINDS |
12/23/2020 |
01/16/2021
|
02/17/2023
|
R21
|
Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional) |
PAR-21-103 |
See Related
|
NIDDK |
12/23/2020 |
01/05/2021
|
01/08/2024
|
U01
|
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed) |
PAR-21-102 |
See Related
|
NIDDK |
12/23/2020 |
01/05/2021
|
01/08/2024
|
U01
|
NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required) |
PAR-21-101 |
See Related
|
NIDDK |
12/23/2020 |
05/09/2021
|
02/16/2024
|
U34
|
NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional) |
PAR-21-092 |
See Related
|
NIDA |
12/21/2020 |
06/26/2021
|
07/26/2023
|
UG3/UH3
|
NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional) |
PAR-20-316 |
See Related
|
NINDS |
12/21/2020 |
08/14/2021
|
09/13/2023
|
U54
|
Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional) |
PAR-21-107 |
See Related
|
NIDCD |
12/17/2020 |
01/25/2021
|
10/27/2023
|
R21
|
NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional) |
PAR-21-093 |
See Related
|
NIDCD |
12/14/2020 |
03/08/2021
|
01/08/2024
|
F32
|
NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) |
PAR-21-097 |
See Related
|
NIAAA |
12/11/2020 |
01/19/2021
|
10/18/2023
|
R34
|
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional) |
PAR-21-098 |
See Related
|
NIAAA |
12/11/2020 |
01/19/2021
|
10/18/2023
|
R61/R33
|
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional) |
PAR-21-064 |
See Related
|
NIDCD |
12/11/2020 |
01/11/2021
|
10/11/2023
|
U01
|
NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required) |
PAR-21-063 |
See Related
|
NIDCD |
12/11/2020 |
01/05/2021
|
01/08/2024
|
R01
|
NIDCD Low Risk Clinical Trials in Communication Disorders (R01 Clinical Trial Required) |
PAR-21-075 |
See Related
|
NHGRI |
12/09/2020 |
04/25/2021
|
05/26/2023
|
R25
|
Research Experiences in Genomic Research for Data Scientists (R25) |
PAR-21-074 |
See Related
|
NHGRI |
12/09/2020 |
04/25/2021
|
05/26/2023
|
R25
|
Mentored Research Experiences for Genetic Counselors (R25) |
PAR-21-086 |
See Related
|
NIDCD |
12/08/2020 |
01/15/2021
|
01/08/2024
|
K01
|
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 No Independent Clinical Trials) |
PAR-21-085 |
See Related
|
NIDCD |
12/08/2020 |
01/18/2021
|
01/08/2024
|
K01
|
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Clinical Trial Required) |
PAR-21-087 |
See Related
|
NIDCD |
12/08/2020 |
01/18/2021
|
01/08/2024
|
K01
|
NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Basic Experimental Studies with Humans Required) |
PAR-21-088 |
See Related
|
NHLBI |
12/02/2020 |
12/25/2020
|
09/26/2023
|
P01
|
NHLBI Program Project Applications (P01 Clinical Trials Optional) |
PAR-21-073 |
See Related
|
NEI |
12/01/2020 |
05/09/2021
|
06/10/2023
|
K12
|
NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional) |
PAR-21-090 |
See Related
|
ORIP |
11/30/2020 |
01/16/2021
|
05/08/2023
|
R03
|
Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trials Not Allowed) |
PAR-21-084 |
See Related
|
NIDCR |
11/25/2020 |
01/08/2021
|
01/08/2024
|
R03
|
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) |
PAR-20-309 |
See Related
|
NIA |
11/24/2020 |
01/05/2021
|
01/08/2024
|
R01
|
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) |
PAR-21-069 |
See Related
|
NIA |
11/23/2020 |
04/07/2021
|
01/08/2024
|
R21
|
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) |
PAR-21-068 |
See Related
|
NIA |
11/23/2020 |
04/07/2021
|
01/08/2024
|
R01
|
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) |
PAR-21-026 |
See Related
|
NIGMS |
11/20/2020 |
01/26/2021
|
01/31/2023
|
T32
|
Graduate Research Training Initiative for Student Enhancement (G-RISE) (T32 - Clinical Trial Not Allowed) |
PAR-21-025 |
See Related
|
NIGMS |
11/20/2020 |
01/26/2021
|
01/31/2023
|
T32
|
Initiative for Maximizing Student Development (IMSD) (T32 - Clinical Trial Not Allowed) |
PAR-21-058 |
See Related
|
NINDS |
11/19/2020 |
01/22/2021
|
09/08/2023
|
U01
|
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) |
PAR-21-056 |
See Related
|
NINDS |
11/19/2020 |
01/22/2021
|
09/08/2023
|
U01
|
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) |
PAR-21-057 |
See Related
|
NINDS |
11/19/2020 |
01/22/2021
|
09/08/2023
|
U44
|
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) |
PAR-21-059 |
See Related
|
NINDS |
11/19/2020 |
01/22/2021
|
09/08/2023
|
U44
|
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) |
PAR-21-078 |
See Related
|
NICHD |
11/19/2020 |
12/15/2020
|
07/16/2022
|
X01
|
Biological Testing Facility (X01 Clinical Trial Not Allowed) |
PAR-21-079 |
See Related
|
NHLBI |
11/18/2020 |
01/16/2021
|
01/08/2024
|
R34
|
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional) |
PAR-21-043 |
See Related
|
NEI |
11/18/2020 |
12/25/2020
|
05/08/2023
|
UG1
|
NEI Collaborative Clinical Vision Project: Resource Center Grant (UG1- Clinical Trial Required) |
PAR-21-042 |
See Related
|
NEI |
11/18/2020 |
12/25/2020
|
05/08/2023
|
UG1
|
NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required) |
PAR-21-041 |
See Related
|
NEI |
11/18/2020 |
12/25/2020
|
05/08/2023
|
UG1
|
NEI Collaborative Clinical Vision Research : Chair's Grant (UG1-Clinical Trial Required) |
PAR-21-065 |
See Related
|
NCI |
11/17/2020 |
12/07/2020
|
01/08/2024
|
R25
|
Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) |
PAR-21-066 |
See Related
|
NCI |
11/17/2020 |
12/07/2020
|
01/08/2024
|
R25
|
Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) |
PAR-21-067 |
See Related
|
NCI |
11/17/2020 |
12/07/2020
|
01/08/2024
|
R25
|
Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) |
PAR-21-081 |
See Related
|
NIMHD |
11/17/2020 |
01/05/2021
|
01/08/2023
|
R01
|
Addressing Health Disparities among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional) |
PAR-21-080 |
See Related
|
NIMHD |
11/17/2020 |
01/05/2021
|
01/08/2023
|
R01
|
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed) |
PA-21-071 |
See Related
|
NIH |
11/16/2020 |
11/10/2020
|
05/08/2023
|
|
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) |
PAR-21-023 |
See Related
|
NIDA |
11/16/2020 |
06/19/2021
|
11/16/2023
|
R34
|
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) |
PAR-21-022 |
See Related
|
NIDA |
11/16/2020 |
06/19/2021
|
11/16/2023
|
R01
|
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) |
PAR-21-070 |
See Related
|
NIAID |
11/13/2020 |
02/17/2021
|
03/18/2023
|
R61/R33
|
Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed) |
PAR-21-072 |
See Related
|
NIAAA |
11/13/2020 |
12/25/2020
|
09/26/2023
|
R24
|
NIAAA Resource-Related Research Projects (R24 Clinical Trial Not Allowed) |
PAR-21-053 |
See Related
|
NIAMS |
11/13/2020 |
02/04/2021
|
11/04/2023
|
R01
|
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) |
PAR-21-045 |
See Related
|
NIAMS |
11/13/2020 |
02/04/2021
|
11/04/2023
|
R21
|
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R21 Clinical Trial Required) |
PAR-21-077 |
See Related
|
NIGMS |
11/13/2020 |
01/16/2021
|
11/17/2022
|
R21/R33
|
Exploring the Scientific Value of Existing or New Sepsis Human Biospecimen Collections (R21/R33 - Clinical Trial Not Allowed) |
PAR-21-033 |
See Related
|
NCI |
11/12/2020 |
12/07/2020
|
01/08/2024
|
R01
|
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) |
PAR-21-036 |
See Related
|
NIAMS |
11/12/2020 |
02/04/2021
|
11/04/2023
|
U01
|
NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) |
PAR-21-035 |
See Related
|
NCI |
11/10/2020 |
12/07/2020
|
01/08/2024
|
R01
|
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) |
PAR-21-039 |
See Related
|
NIH |
11/09/2020 |
12/26/2020
|
12/29/2023
|
R01
|
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Basic Experimental Studies with Humans Required) |
PAR-21-038 |
See Related
|
NIH |
11/09/2020 |
12/26/2020
|
12/29/2023
|
R01
|
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) |
PAR-20-315 |
See Related
|
NIH |
11/05/2020 |
11/06/2020
|
10/01/2023
|
R00
|
Limited Competition: Lasker Clinical Research Scholars Transition Award (R00 Clinical Trial Optional) |
PA-21-052 |
See Related
|
NIH |
10/28/2020 |
11/08/2020
|
09/08/2023
|
F31
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) |
PAR-20-236 |
See Related
|
NIDA |
10/28/2020 |
02/15/2021
|
11/16/2023
|
R25
|
Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed) |
PAR-20-311 |
See Related
|
NINDS |
10/27/2020 |
12/25/2020
|
01/26/2023
|
R25
|
NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and Stroke (R25 - Clinical Trial Not Allowed) |
PA-21-050 |
See Related
|
NIH |
10/26/2020 |
11/08/2020
|
12/09/2023
|
F30
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) |
PA-21-049 |
See Related
|
NIH |
10/26/2020 |
11/08/2020
|
09/08/2023
|
F30
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) |
PA-21-048 |
See Related
|
NIH |
10/26/2020 |
11/08/2020
|
09/08/2023
|
F32
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) |
PAR-21-054 |
See Related
|
NIAMS |
10/22/2020 |
02/18/2021
|
12/03/2022
|
R21
|
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) |
PAR-21-055 |
See Related
|
NIAMS |
10/22/2020 |
02/18/2021
|
12/03/2022
|
R01
|
Mechanistic Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) |
PA-21-047 |
See Related
|
NIH |
10/22/2020 |
11/08/2020
|
09/08/2023
|
F33
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) |
PA-21-051 |
See Related
|
NIH |
10/21/2020 |
11/08/2020
|
09/08/2023
|
F31
|
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) |
PAR-21-037 |
See Related
|
NIAID |
10/20/2020 |
06/28/2021
|
07/29/2023
|
G11
|
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed) |
PAR-21-034 |
See Related
|
NIDDK |
10/19/2020 |
12/28/2020
|
02/01/2023
|
R25
|
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed) |
PAR-21-032 |
See Related
|
NINDS |
10/15/2020 |
01/11/2021
|
01/08/2024
|
F32
|
NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed) |
PAR-21-046 |
See Related
|
NLM |
10/14/2020 |
01/26/2021
|
02/25/2023
|
G13
|
NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed) |
PAR-21-028 |
See Related
|
NIMH |
10/14/2020 |
01/16/2021
|
01/08/2024
|
R21
|
Discovery of Cell-based Chemical Probes for Novel Brain Targets (R21 Clinical Trial Not Allowed) |
PAR-21-029 |
See Related
|
NIMH |
10/14/2020 |
01/05/2021
|
01/08/2024
|
R01
|
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed) |
PAR-20-314 |
See Related
|
NCI |
10/13/2020 |
01/18/2021
|
10/11/2023
|
UH3
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) |
PAR-20-313 |
See Related
|
NCI |
10/13/2020 |
01/18/2021
|
10/11/2023
|
UH2/UH3
|
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) |
PA-20-272 |
See Related
|
NIH |
10/13/2020 |
10/09/2020
|
10/24/2023
|
|
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) |
PAR-20-306 |
See Related
|
NIDCR |
10/08/2020 |
10/19/2020
|
09/08/2023
|
UG3/UH3
|
National Dental Practice-Based Research Network Clinical Trial or Observational Study Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Optional) |
PAR-21-030 |
See Related
|
NIAMS |
10/08/2020 |
12/05/2020
|
09/06/2022
|
R43/R44
|
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) |
PAR-20-307 |
See Related
|
NIMH |
10/08/2020 |
08/13/2021
|
09/14/2023
|
P30
|
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) |
PAR-20-308 |
See Related
|
NIMH |
10/08/2020 |
08/13/2021
|
09/14/2023
|
P30
|
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) |
PA-20-275 |
See Related
|
NIH |
10/06/2020 |
07/24/2020
|
07/24/2023
|
|
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
PAR-21-027 |
See Related
|
NHLBI |
09/30/2020 |
12/07/2020
|
01/08/2023
|
R01
|
Multidisciplinary Approaches to HIV-Associated Comorbidities and Prioritizing Intervention Targets (R01 Clinical Trial Not Allowed) |
PAR-20-310 |
See Related
|
NIMHD |
09/30/2020 |
10/27/2020
|
03/28/2023
|
R01
|
Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) |
PAR-21-044 |
See Related
|
NIDA |
09/29/2020 |
03/30/2021
|
11/01/2023
|
X01
|
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) |
PAR-20-305 |
See Related
|
NCI |
09/28/2020 |
12/25/2020
|
01/08/2024
|
P50
|
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, and 2023 (P50 Clinical Trial Required) |
PAR-20-312 |
See Related
|
NIOSH |
09/24/2020 |
09/30/2020
|
09/15/2022
|
U60
|
State Occupational Safety and Health Surveillance Program (U60) |
PAR-20-301 |
See Related
|
NCATS |
09/18/2020 |
01/09/2021
|
06/10/2023
|
UG3/UH3
|
Drug Development Collaboratory (UG3/UH3 Clinical Trial Required) |
PAR-20-289 |
See Related
|
NIAID |
09/17/2020 |
11/06/2020
|
09/08/2022
|
R25
|
NIAID Research Education Program (R25 Clinical Trial Not Allowed) |
PAR-20-304 |
See Related
|
NLM |
09/15/2020 |
01/05/2021
|
05/08/2023
|
R01
|
Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) |
PAR-20-291 |
See Related
|
NIAID |
09/14/2020 |
09/16/2020
|
09/08/2023
|
R21
|
Limited Competition: Exploratory and Developmental Research Grant Program for NIAID K01/K08/K23 Recipients (R21 Clinical Trial Not Allowed) |
PAR-20-290 |
See Related
|
NIAID |
09/14/2020 |
09/16/2020
|
09/08/2023
|
R03
|
Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03 Clinical Trial Not Allowed) |
PAR-20-300 |
See Related
|
NICHD |
09/11/2020 |
11/10/2020
|
12/10/2022
|
R01
|
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional) |
PAR-20-299 |
See Related
|
NICHD |
09/11/2020 |
11/10/2020
|
12/10/2022
|
R21
|
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional) |
PAR-20-293 |
See Related
|
NIMH |
09/10/2020 |
04/17/2021
|
05/18/2023
|
P50
|
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) |
PAR-20-298 |
See Related
|
NICHD |
09/09/2020 |
03/07/2021
|
12/08/2023
|
R01
|
Development of the Fetal Immune System (R01 Clinical Trial Not Allowed) |
PAR-20-296 |
See Related
|
NIGMS |
09/09/2020 |
05/18/2021
|
06/20/2023
|
R25
|
Modules for Enhancing Biomedical Research Workforce Training (R25 Clinical Trial Not Allowed) |
PAR-20-303 |
See Related
|
NCI |
09/04/2020 |
10/12/2020
|
09/08/2023
|
R21
|
Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional) |
PAR-20-302 |
See Related
|
NCI |
09/04/2020 |
10/12/2020
|
09/08/2023
|
R01
|
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) |
PAR-21-024 |
See Related
|
NIAID |
09/03/2020 |
02/15/2021
|
03/16/2023
|
P01
|
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed) |
PAR-20-295 |
See Related
|
NCI |
08/28/2020 |
01/10/2021
|
10/14/2021
|
R01
|
Clinical Translation of Activated Optical Fluorescence Methods and Technologies for Sensitive Cancer Detection in Vivo (R01 Clinical Trial Optional) |
PAR-20-274 |
See Related
|
NIDA |
08/28/2020 |
10/18/2020
|
08/12/2023
|
R34
|
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 - Clinical Trial Optional ) |
PAR-20-273 |
See Related
|
NIDA |
08/28/2020 |
10/18/2020
|
08/12/2023
|
R01
|
New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required) |
PAR-20-297 |
See Related
|
NIOSH |
08/26/2020 |
08/28/2020
|
10/31/2023
|
U19
|
NIOSH Centers of Excellence for Total Worker Health (U19) |
PAR-20-292 |
See Related
|
NCI |
08/24/2020 |
09/20/2020
|
07/21/2022
|
R21
|
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
PAR-20-258 |
See Related
|
NIAID |
08/24/2020 |
09/12/2020
|
01/08/2023
|
K01
|
Mentored Career Development Program (K01) for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed) |
PAR-20-283 |
See Related
|
NLM |
08/19/2020 |
09/23/2020
|
10/22/2022
|
G08
|
NLM Information Resource Grants to Reduce Health Disparities (G08 Clinical Trial Not Allowed). |
PA-20-074 |
See Related
|
AHRQ |
08/17/2020 |
08/19/2020
|
01/26/2022
|
R18
|
Disseminating and Implementing Patient-Centered Outcomes Research (PCOR) Evidence into Practice through Interoperable Clinical Decision Support |
PAR-20-238 |
See Related
|
NIDA |
08/17/2020 |
04/17/2021
|
09/08/2023
|
R01
|
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) |
PAR-20-214 |
See Related
|
NIDA |
08/17/2020 |
04/17/2021
|
09/08/2023
|
R21
|
Research to Improve Native American Health (R21 Clinical Trials Optional) |
PAR-20-259 |
See Related
|
NIAID |
08/14/2020 |
10/02/2020
|
10/15/2022
|
DP2
|
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed) |
PAR-20-284 |
See Related
|
NCI |
08/13/2020 |
10/04/2020
|
05/05/2023
|
R01
|
Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) |
PAR-20-264 |
See Related
|
NIMH |
08/10/2020 |
09/16/2020
|
09/08/2023
|
R21
|
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) |
PAR-20-263 |
See Related
|
NIMH |
08/10/2020 |
09/05/2020
|
09/08/2023
|
R01
|
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed) |
PAR-20-280 |
See Related
|
NIOSH |
08/07/2020 |
11/02/2020
|
12/13/2024
|
U01
|
Cooperative Research Agreements Related to the World Trade Center Health Program (U01) |
PAR-20-270 |
See Related
|
NIAID |
08/05/2020 |
08/14/2020
|
05/13/2023
|
R34
|
NIAID Clinical Trial Planning Grant (R34 Clinical Trials Not Allowed) |
PAR-20-294 |
See Related
|
NCI |
08/05/2020 |
10/12/2020
|
11/10/2022
|
U01
|
Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed) |
PAR-20-286 |
See Related
|
NIMH |
08/05/2020 |
09/19/2020
|
02/19/2022
|
P50
|
Practice-Based Suicide Prevention Research Centers (P50 Clinical Trial Optional) |
PA-20-252 |
See Related
|
ODS |
07/30/2020 |
09/15/2020
|
04/16/2022
|
|
Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) |
PAR-20-285 |
See Related
|
NINDS |
07/29/2020 |
09/14/2020
|
07/24/2023
|
UG3/UH3
|
NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention (UG3/UH3 Clinical Trial Optional) |
PAR-20-257 |
See Related
|
NHGRI |
07/29/2020 |
09/19/2020
|
07/20/2023
|
R03
|
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03) Clinical Trial Optional) |
PAR-20-254 |
See Related
|
NHGRI |
07/28/2020 |
09/19/2020
|
07/20/2023
|
R01
|
Ethical, Legal and Social Implications (ELSI) (Research R01 Clinical Trial Optional) |
PAR-20-255 |
See Related
|
NHGRI |
07/28/2020 |
09/19/2020
|
07/20/2023
|
R21
|
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21) (Clinical Trial Optional) |
PAR-20-279 |
See Related
|
NIDA |
07/27/2020 |
11/15/2020
|
08/11/2023
|
UG3/UH3
|
Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional) |
PAR-20-281 |
See Related
|
NICHD |
07/23/2020 |
09/19/2020
|
06/20/2023
|
R01
|
Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional) |
PAR-20-282 |
See Related
|
NICHD |
07/23/2020 |
09/19/2020
|
06/20/2023
|
R21
|
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed) |
PAR-20-277 |
See Related
|
NCI |
07/22/2020 |
09/16/2020
|
09/08/2022
|
R21
|
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) |
PAR-20-276 |
See Related
|
NCI |
07/22/2020 |
09/05/2020
|
09/08/2022
|
R01
|
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) |
PAR-20-271 |
See Related
|
NCI |
07/20/2020 |
09/05/2020
|
01/08/2023
|
R01
|
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) |
PAR-20-267 |
See Related
|
NIDA |
07/17/2020 |
08/25/2020
|
11/18/2022
|
P30
|
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) |
PAR-20-266 |
See Related
|
NCCIH |
07/15/2020 |
09/02/2020
|
06/20/2023
|
R61/R33
|
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) |
PAR-20-256 |
See Related
|
NIAID |
07/13/2020 |
07/13/2020
|
07/08/2021
|
S10
|
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) |
PAR-20-129 |
See Related
|
NIH |
07/10/2020 |
03/05/2020
|
04/06/2022
|
SB1
|
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) |
PAR-20-128 |
See Related
|
NIH |
07/10/2020 |
03/05/2020
|
04/06/2022
|
SB1
|
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed) |
PAR-20-130 |
See Related
|
NIH |
07/10/2020 |
03/05/2020
|
04/06/2022
|
SB1
|
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) |
PAR-20-253 |
See Related
|
NINDS |
07/07/2020 |
04/26/2021
|
05/31/2023
|
R21
|
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed) |
PAR-20-249 |
See Related
|
NIDA |
07/01/2020 |
02/01/2021
|
11/16/2023
|
K12
|
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) |
PAR-20-250 |
See Related
|
NICHD |
06/29/2020 |
08/25/2020
|
05/26/2022
|
R25
|
NICHD Research Education Programs (R25 Clinical Trial Not Allowed) |
PAR-20-244 |
See Related
|
NIGMS |
06/25/2020 |
08/04/2020
|
09/03/2022
|
R43/R44
|
Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (SBIR) (R43/R44 Clinical Trial Not Allowed) |
PAR-20-239 |
See Related
|
NIGMS |
06/25/2020 |
08/04/2020
|
09/03/2022
|
R41/R42
|
Interactive Digital Media STEM Resources for Pre-College and Informal Science Education Audiences (STTR) (R41/R42 Clinical Trial Not Allowed) |
PAR-20-240 |
See Related
|
NINDS |
06/25/2020 |
12/25/2020
|
09/27/2022
|
R25
|
NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed) |
PAR-20-212 |
See Related
|
ORIP |
06/16/2020 |
08/07/2020
|
09/08/2022
|
R21
|
Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed) |
PAR-20-231 |
See Related
|
ORIP |
06/16/2020 |
08/07/2020
|
09/08/2022
|
K01
|
HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed) |
PAR-20-233 |
See Related
|
NIDCR |
06/16/2020 |
09/05/2020
|
05/08/2023
|
R01
|
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not Allowed) |
PAR-20-232 |
See Related
|
NIDCR |
06/16/2020 |
09/16/2020
|
05/08/2023
|
R21
|
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not Allowed) |
PAR-20-235 |
See Related
|
NIMH |
06/15/2020 |
09/05/2020
|
09/08/2023
|
R01
|
Behavioral Tasks Targeting Brain Systems Relevant to Anhedonia (R01 Basic Experimental Studies with Humans Required) |
PAR-20-230 |
See Related
|
NHGRI |
06/11/2020 |
06/15/2020
|
07/09/2023
|
X01
|
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01) |
PA-20-227 |
See Related
|
ODS |
06/09/2020 |
09/15/2020
|
04/16/2023
|
|
Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed) |
PAR-20-228 |
See Related
|
ODS |
06/08/2020 |
09/01/2020
|
10/15/2022
|
R03
|
Pilot Projects Increasing the Impact of the NIH Centers for Advancing Research on Botanicals and Other Natural Products (PI2 CARBON) (R03 Clinical Trials Not Allowed) |
PAR-20-211 |
See Related
|
OPPNET |
06/03/2020 |
02/16/2021
|
03/18/2023
|
K18
|
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials) |
PAR-20-226 |
See Related
|
OPPNET |
06/03/2020 |
02/16/2021
|
03/18/2023
|
K18
|
Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required) |
PAR-20-213 |
See Related
|
NIGMS |
06/01/2020 |
08/25/2020
|
05/26/2023
|
T32
|
National Institute of General Medical Sciences Institutional Predoctoral Research Training Grant (T32 - Clinical Trial Not Allowed) |
PAR-20-225 |
See Related
|
NIDA |
06/01/2020 |
09/19/2020
|
10/20/2022
|
DP1
|
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) |
PAR-20-224 |
See Related
|
NIDA |
06/01/2020 |
07/13/2020
|
08/16/2022
|
DP2
|
Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional) |
PAR-20-221 |
See Related
|
NIDA |
06/01/2020 |
07/13/2020
|
08/16/2022
|
DP1
|
NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional) |
PAR-20-223 |
See Related
|
NIBIB |
06/01/2020 |
06/24/2020
|
06/25/2022
|
R25
|
Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25) |
PAR-20-220 |
See Related
|
NIDDK |
05/28/2020 |
09/14/2020
|
10/15/2022
|
U2C
|
Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C/TL1 - Clinical Trial Not Allowed) |
PAR-20-181 |
See Related
|
ORIP |
05/27/2020 |
08/25/2020
|
05/26/2023
|
P51
|
Limited Competition: National Primate Research Centers (P51) Program |
PAR-20-219 |
See Related
|
NCCIH |
05/20/2020 |
06/20/2020
|
05/08/2023
|
U24
|
Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required) |
PAR-20-218 |
See Related
|
NCCIH |
05/20/2020 |
06/20/2020
|
05/08/2023
|
R61/R33
|
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) |
PAR-20-217 |
See Related
|
NCCIH |
05/20/2020 |
06/20/2020
|
05/08/2023
|
R33
|
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) |
PAR-20-216 |
See Related
|
NCCIH |
05/20/2020 |
06/20/2020
|
05/08/2023
|
U01
|
NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) |
PAR-20-215 |
See Related
|
NCCIH |
05/20/2020 |
06/20/2020
|
05/08/2023
|
UG3/UH3
|
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) |
PAR-20-210 |
See Related
|
NIAID |
05/14/2020 |
05/12/2020
|
01/08/2023
|
K99/R00
|
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed) |
PAR-20-209 |
See Related
|
NIAID |
05/14/2020 |
05/12/2020
|
01/08/2023
|
K99/R00
|
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required) |
PA-20-151 |
See Related
|
NIMH |
05/13/2020 |
08/07/2020
|
05/08/2023
|
R01
|
Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed) |
PA-20-149 |
See Related
|
NIMH |
05/13/2020 |
08/07/2020
|
05/08/2023
|
R01
|
HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed) |
PA-20-203 |
See Related
|
NIH |
05/12/2020 |
05/12/2020
|
05/08/2023
|
K08
|
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) |
PA-20-202 |
See Related
|
NIH |
05/12/2020 |
05/12/2020
|
05/08/2023
|
K08
|
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) |
PA-20-201 |
See Related
|
NIH |
05/12/2020 |
05/12/2020
|
05/08/2023
|
K08
|
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required) |
PA-20-206 |
See Related
|
NIH |
05/12/2020 |
05/12/2020
|
05/08/2023
|
K23
|
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required) |
PA-20-205 |
See Related
|
NIH |
05/11/2020 |
05/12/2020
|
05/08/2023
|
K23
|
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) |
PA-20-204 |
See Related
|
NIH |
05/11/2020 |
05/12/2020
|
05/08/2023
|
K23
|
Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required) |
PA-20-208 |
See Related
|
NIDA |
05/08/2020 |
05/16/2020
|
05/08/2023
|
R36
|
Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional) |
PA-20-199 |
See Related
|
NIH |
05/07/2020 |
05/12/2020
|
05/08/2023
|
K25
|
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed) |
PA-20-197 |
See Related
|
NIH |
05/07/2020 |
05/12/2020
|
05/08/2023
|
K25
|
Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required) |
PA-20-198 |
See Related
|
NIH |
05/07/2020 |
05/12/2020
|
05/08/2023
|
K25
|
Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required) |
PA-20-200 |
See Related
|
NIH |
05/07/2020 |
05/16/2020
|
05/08/2023
|
R03
|
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed) |
PA-20-195 |
See Related
|
NIH |
05/07/2020 |
05/16/2020
|
05/08/2023
|
R21
|
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) |
PA-20-194 |
See Related
|
NIH |
05/07/2020 |
05/16/2020
|
05/08/2023
|
R21
|
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) |
PA-20-196 |
See Related
|
NIH |
05/07/2020 |
05/16/2020
|
05/08/2023
|
R21
|
NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required) |
PA-20-176 |
See Related
|
NIH |
05/07/2020 |
05/12/2020
|
05/08/2023
|
K01
|
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required) |
PA-20-191 |
See Related
|
NIH |
05/07/2020 |
05/12/2020
|
05/08/2023
|
K01
|
Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required) |
PA-20-190 |
See Related
|
NIH |
05/07/2020 |
05/12/2020
|
05/08/2023
|
K01
|
Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) |
PA-20-192 |
See Related
|
NIH |
05/06/2020 |
05/12/2020
|
05/08/2023
|
K24
|
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Basic Experimental Studies with Humans Required) |
PA-20-193 |
See Related
|
NIH |
05/06/2020 |
05/12/2020
|
05/08/2023
|
K24
|
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) |
PA-20-186 |
See Related
|
NIH |
05/06/2020 |
05/12/2020
|
05/08/2023
|
K24
|
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed) |
PA-20-187 |
See Related
|
NIH |
05/05/2020 |
05/12/2020
|
05/08/2023
|
K99/R00
|
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required) |
PA-20-188 |
See Related
|
NIH |
05/05/2020 |
05/12/2020
|
05/08/2023
|
K99/R00
|
NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed) |
PA-20-189 |
See Related
|
NIH |
05/05/2020 |
05/12/2020
|
05/08/2023
|
K99/R00
|
NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required) |
PA-20-185 |
See Related
|
NIH |
05/05/2020 |
05/05/2020
|
05/08/2023
|
R01
|
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) |
PA-20-184 |
See Related
|
NIH |
05/05/2020 |
05/05/2020
|
05/08/2023
|
R01
|
Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required) |
PA-20-183 |
See Related
|
NIH |
05/05/2020 |
05/05/2020
|
05/08/2023
|
R01
|
Research Project Grant (Parent R01 Clinical Trial Required) |
PAR-20-179 |
See Related
|
ODP |
04/30/2020 |
09/05/2020
|
09/08/2023
|
R01
|
Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional) |
PAR-20-180 |
See Related
|
ODP |
04/30/2020 |
09/05/2020
|
09/08/2023
|
R01
|
Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) |
PAR-20-175 |
See Related
|
NIGMS |
04/24/2020 |
09/07/2020
|
10/08/2022
|
U54
|
IDeA Program Infrastructure for Clinical and Translational Research (IDeA-CTR)(U54 - Clinical Trial Optional) |
PA-20-174 |
See Related
|
NIH |
04/23/2020 |
05/12/2020
|
05/08/2023
|
K02
|
Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed) |
PA-20-173 |
See Related
|
NIH |
04/23/2020 |
05/12/2020
|
05/08/2023
|
K02
|
Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required) |
PA-20-171 |
See Related
|
NIH |
04/23/2020 |
05/12/2020
|
05/08/2023
|
K02
|
Independent Scientist Award (Parent K02 - Independent Clinical Trial Required) |
PA-20-172 |
See Related
|
NIMHD |
04/20/2020 |
09/04/2020
|
09/08/2023
|
R01
|
Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) |
PAR-20-170 |
See Related
|
NCI |
04/15/2020 |
10/18/2020
|
06/07/2023
|
U01
|
New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional) |
PAR-20-169 |
See Related
|
NIBIB |
04/14/2020 |
04/25/2020
|
05/08/2023
|
P41
|
National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional) |
PAR-20-165 |
See Related
|
NINDS |
04/13/2020 |
05/05/2020
|
03/06/2023
|
R01
|
Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed) |
PAR-20-168 |
See Related
|
NINDS |
04/13/2020 |
05/16/2020
|
05/08/2023
|
R21
|
Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed) |
PA-20-163 |
See Related
|
NIH |
04/03/2020 |
03/17/2020
|
03/17/2023
|
|
Competing Revisions to Existing NIH Grants and Cooperative Agreements (Clinical Trial Optional) |
PAR-20-164 |
See Related
|
NIMHD |
04/03/2020 |
06/12/2020
|
07/15/2022
|
R01
|
Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed) |
PA-20-162 |
See Related
|
NIH |
04/02/2020 |
04/25/2020
|
05/08/2023
|
T35
|
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35) |
PAR-20-161 |
See Related
|
NICHD |
04/02/2020 |
08/14/2020
|
03/18/2023
|
X01
|
Catalyzing Innovation in Pediatric Pharmacology Clinical Trial Design and Resource Access (X01 Clinical Trial Not Allowed) |
PAR-20-157 |
See Related
|
NIMH |
03/31/2020 |
05/05/2020
|
05/08/2023
|
R01
|
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) |
PAR-20-159 |
See Related
|
NIMH |
03/31/2020 |
05/16/2020
|
05/08/2023
|
R21
|
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional) |
PAS-20-160 |
See Related
|
NIDDK |
03/31/2020 |
05/05/2020
|
05/08/2023
|
R01
|
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required) |
PAR-20-158 |
See Related
|
NIAID |
03/31/2020 |
06/29/2020
|
07/29/2022
|
R01
|
Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed) |
PAR-20-156 |
See Related
|
NIA |
03/31/2020 |
05/05/2020
|
05/08/2023
|
R01
|
Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) |
PAR-20-155 |
See Related
|
NCI |
03/30/2020 |
05/05/2020
|
09/08/2022
|
R01
|
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
PAR-20-154 |
See Related
|
NCCIH |
03/30/2020 |
05/05/2020
|
05/08/2023
|
R01
|
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) |
PAR-20-153 |
See Related
|
NIGMS |
03/30/2020 |
06/14/2020
|
07/14/2022
|
R25
|
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) |
PAR-20-150 |
See Related
|
NIMHD |
03/26/2020 |
05/16/2020
|
05/08/2023
|
R21
|
NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) |
PAR-20-148 |
See Related
|
NIDA |
03/25/2020 |
09/13/2020
|
05/08/2023
|
R21
|
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) |
PAR-20-147 |
See Related
|
NIDA |
03/25/2020 |
09/13/2020
|
05/08/2023
|
R01
|
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed) |
PA-20-146 |
See Related
|
NIDA |
03/24/2020 |
05/16/2020
|
05/08/2023
|
R03
|
NIDA Small Research Grant Program (R03 Clinical Trial Required) |
PA-20-145 |
See Related
|
NIMH |
03/23/2020 |
04/07/2020
|
01/08/2023
|
R21
|
Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional) |
PA-20-144 |
See Related
|
NIMH |
03/23/2020 |
04/07/2020
|
01/08/2023
|
R01
|
Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional) |
PA-20-142 |
See Related
|
NIH |
03/20/2020 |
04/25/2020
|
05/26/2023
|
T32
|
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) |
PA-20-141 |
See Related
|
NIMH |
03/19/2020 |
04/07/2020
|
01/08/2023
|
R34
|
Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) |
PAR-20-140 |
See Related
|
NIDDK |
03/16/2020 |
05/16/2020
|
05/08/2023
|
R21
|
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) |
PAR-20-138 |
See Related
|
NCCIH |
03/16/2020 |
04/25/2020
|
05/08/2023
|
P01
|
Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional) |
PAR-20-139 |
See Related
|
NIAID |
03/13/2020 |
04/13/2020
|
01/14/2023
|
R01
|
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) |
PAR-20-131 |
See Related
|
NCI |
03/12/2020 |
05/05/2020
|
05/08/2023
|
R01
|
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
PAR-20-137 |
See Related
|
NICHD |
03/12/2020 |
05/05/2020
|
11/06/2022
|
R01
|
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
PAR-20-134 |
See Related
|
NIDDK |
03/11/2020 |
05/18/2020
|
06/09/2021
|
R21/R33
|
Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required) |
PAR-20-133 |
See Related
|
NIDDK |
03/11/2020 |
05/18/2020
|
06/09/2021
|
R21/R33
|
Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required) |
PA-20-135 |
See Related
|
NIH |
03/10/2020 |
03/03/2020
|
09/08/2025
|
|
Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) |
PAS-20-121 |
See Related
|
NIAID |
03/06/2020 |
04/07/2020
|
01/08/2022
|
R21
|
Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed) |
PAR-20-126 |
See Related
|
NICHD |
03/05/2020 |
04/25/2020
|
05/08/2023
|
P41
|
NICHD Biomedical Informatic Resource Centers Grants (P41 Clinical Trial Not Allowed) |
PAR-20-125 |
See Related
|
NIGMS |
03/05/2020 |
05/24/2020
|
07/24/2021
|
S06
|
Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional) |
PAR-20-123 |
See Related
|
NIDCD |
03/05/2020 |
04/07/2020
|
01/08/2023
|
R21
|
Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional) |
PAR-20-127 |
See Related
|
NIDCD |
03/05/2020 |
04/07/2020
|
01/08/2023
|
R01
|
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) |
PAR-20-124 |
See Related
|
FDA |
03/05/2020 |
03/09/2020
|
05/03/2022
|
U01
|
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens (U01) Clinical Trials Not Allowed |
PAR-20-120 |
See Related
|
NIAID |
03/03/2020 |
06/28/2020
|
03/10/2022
|
U19
|
Integrated Preclinical / Clinical AIDS Vaccine Development Program (IPCAVD)
(U19 Clinical Trial Not Allowed) |
PAR-20-111 |
See Related
|
NINDS |
03/03/2020 |
07/11/2020
|
05/08/2023
|
U44
|
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) |
PAR-20-122 |
See Related
|
NINDS |
03/03/2020 |
07/11/2020
|
05/08/2023
|
UG3/UH3
|
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) |
PAR-20-119 |
See Related
|
NIMH |
02/25/2020 |
02/25/2020
|
03/26/2022
|
U19
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U19 Clinical Trial Optional) |
PAR-20-118 |
See Related
|
NIMH |
02/25/2020 |
06/27/2020
|
03/26/2022
|
U01
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional) |
PAR-20-117 |
See Related
|
NIGMS |
02/24/2020 |
09/02/2020
|
10/04/2022
|
R35
|
Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional) |
PAR-20-116 |
See Related
|
NCI |
02/24/2020 |
04/21/2020
|
11/19/2021
|
R01
|
Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) |
PAR-20-115 |
See Related
|
NIGMS |
02/20/2020 |
04/28/2020
|
05/28/2022
|
P30
|
Limited Competition: Centers of Biomedical Research Excellence (COBRE) Phase III - Transitional Centers (P30 Clinical Trial Optional) |
PAR-20-110 |
See Related
|
NIA |
02/07/2020 |
04/25/2020
|
01/26/2023
|
U24
|
National Institute on Aging Genetics of Alzheimer's Disease Data Storage Site (U24 Clinical Trial Not Allowed) |
PAR-20-098 |
See Related
|
NCATS |
02/06/2020 |
03/05/2020
|
01/06/2022
|
R43/R44
|
Non-Viral Technologies for in vivo Delivery of Genome Editors (R43/R44 Clinical Trial Not Allowed) |
PAR-20-109 |
See Related
|
NCATS |
02/06/2020 |
03/05/2020
|
01/06/2022
|
R41/R42
|
Non-Viral Technologies for in vivo Delivery of Genome Editors (R41/R42 Clinical Trial Not Allowed) |
PAR-20-105 |
See Related
|
FDA |
02/05/2020 |
02/05/2020
|
04/07/2022
|
U19
|
Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed |
PAR-20-108 |
See Related
|
NIAID |
02/04/2020 |
06/15/2020
|
08/20/2022
|
R01
|
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) |
PAR-20-106 |
See Related
|
NIAID |
02/03/2020 |
06/29/2020
|
07/29/2022
|
P30
|
Centers for AIDS Research (P30 Clinical Trial Not Allowed) |
PAR-20-107 |
See Related
|
NIAID |
02/03/2020 |
06/29/2020
|
07/29/2022
|
P30
|
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) |
PAR-20-104 |
See Related
|
NIGMS |
02/03/2020 |
04/26/2020
|
01/27/2023
|
RM1
|
Biomedical Technology Development and Dissemination Center (RM1 - Clinical Trial Not Allowed) |
PAR-20-103 |
See Related
|
NIGMS |
01/29/2020 |
04/27/2020
|
01/28/2023
|
RM1
|
Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) |
PAR-20-102 |
See Related
|
NIGMS |
01/29/2020 |
04/20/2020
|
05/21/2022
|
P20
|
IDeA Networks of Biomedical Research Excellence (INBRE) (P20 Clinical Trial Optional) |
PAR-20-077 |
See Related
|
NCI |
01/27/2020 |
04/07/2020
|
05/08/2023
|
P01
|
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) |
PAR-20-092 |
See Related
|
NIDA |
01/24/2020 |
01/24/2020
|
09/02/2022
|
UG3/UH3
|
Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) |
PAR-20-101 |
See Related
|
NICHD |
01/23/2020 |
04/27/2020
|
05/27/2022
|
U24
|
Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed) |
PAR-20-099 |
See Related
|
NIA |
01/23/2020 |
04/25/2020
|
01/26/2023
|
U24
|
Harmonization of Alzheimers Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed) |
PAR-20-100 |
See Related
|
NHGRI |
01/23/2020 |
04/25/2020
|
05/26/2023
|
U24
|
Genomic Community Resources (U24 Clinical Trial Not Allowed) |
PAR-20-097 |
See Related
|
NIGMS |
01/17/2020 |
08/25/2020
|
05/09/2023
|
U24
|
Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed) |
PAR-20-089 |
See Related
|
NIGMS |
01/17/2020 |
08/25/2020
|
05/09/2023
|
U24
|
Biomedical Data Repository (U24 - Clinical Trials Not Allowed) |
PAR-20-094 |
See Related
|
NIMH |
01/16/2020 |
04/26/2020
|
05/26/2022
|
R25
|
NIMH Research Education Programs for Psychiatry Residents (R25- Independent Clinical Trial Not Allowed) |
PAR-20-080 |
See Related
|
NIMH |
01/16/2020 |
04/26/2020
|
05/26/2022
|
R25
|
NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed) |
PAR-20-093 |
See Related
|
NIMH |
01/16/2020 |
04/27/2020
|
05/25/2022
|
P50
|
Silvio O. Conte Centers for Basic Neuroscience or Translational Mental Health Research (P50 Clinical Trial Optional) |
PAR-20-095 |
See Related
|
NIA |
01/16/2020 |
04/25/2020
|
01/26/2023
|
R25
|
Development of Research Education Resources for Geriatrics-Related Translational and Clinical Scientists (R25 Independent Clinical Trial Not Allowed) |
PAR-20-096 |
See Related
|
NIMH |
01/16/2020 |
04/26/2020
|
05/26/2022
|
R25
|
NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed) |
PAR-20-088 |
See Related
|
NIMHD |
01/14/2020 |
03/01/2020
|
04/02/2022
|
R01
|
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) |
PAR-20-081 |
See Related
|
NIMHD |
01/14/2020 |
03/01/2020
|
04/02/2022
|
R21
|
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed) |
PAR-20-090 |
See Related
|
NIAMS |
01/14/2020 |
02/02/2020
|
11/02/2022
|
R34
|
NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed |
PA-20-047 |
See Related
|
NIMH |
01/07/2020 |
03/05/2020
|
01/06/2023
|
R43/R44
|
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed) |
PA-20-025 |
See Related
|
NIMH |
01/07/2020 |
03/05/2020
|
01/06/2023
|
R41/R42
|
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed) |
PAR-20-038 |
See Related
|
NIMH |
01/07/2020 |
01/08/2020
|
01/08/2023
|
R01
|
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) |
PAR-20-037 |
See Related
|
NIMH |
01/07/2020 |
01/08/2020
|
01/08/2023
|
R01
|
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) |
PAR-20-084 |
See Related
|
NIBIB |
01/07/2020 |
01/17/2020
|
01/08/2023
|
R21
|
NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) |
PAR-20-083 |
See Related
|
FDA |
01/07/2020 |
01/10/2020
|
04/11/2022
|
U01
|
Enhancing Regulatory Science for Advancing Pharmaceutical Quality and Manufacturing (U01) Clinical Trials Optional |
PAR-20-055 |
See Related
|
NIMH |
01/03/2020 |
01/05/2020
|
01/08/2023
|
R01
|
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) |
PAR-20-082 |
See Related
|
NIMH |
01/03/2020 |
01/16/2020
|
01/08/2023
|
R21
|
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) |
PAR-20-079 |
See Related
|
NIMHD |
12/30/2019 |
05/05/2020
|
07/06/2022
|
R01
|
Surgical Disparities Research (R01 - Clinical Trial Optional) |
PAR-20-078 |
See Related
|
NHLBI |
12/19/2019 |
01/26/2020
|
11/26/2022
|
R21
|
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) |
PAR-20-075 |
See Related
|
NIDDK |
12/11/2019 |
02/18/2020
|
01/08/2023
|
P01
|
Limited Competition: NIDDK Program Projects (P01 Clinical Trial Optional) |
PAR-20-076 |
See Related
|
NINDS |
12/11/2019 |
04/26/2020
|
05/26/2022
|
T32
|
Jointly Sponsored Ruth L. Kirschstein National Research Service Award Institutional Predoctoral Training Program in the Neurosciences (T32 Clinical Trial Not Allowed) |
PAR-20-074 |
See Related
|
NCI |
12/10/2019 |
01/28/2020
|
10/29/2022
|
R01
|
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) |
PAR-20-073 |
See Related
|
NIDCR |
12/09/2019 |
01/24/2020
|
09/02/2022
|
X01
|
National Dental Practice-Based Research Network Infrastructure Access (X01 Clinical Trial Not Allowed) |
PAR-20-072 |
See Related
|
NIAID |
12/09/2019 |
12/09/2019
|
09/08/2022
|
P01
|
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) |
PAR-20-070 |
See Related
|
NIA |
12/09/2019 |
01/16/2020
|
11/17/2022
|
R21/R33
|
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional) |
PAR-20-071 |
See Related
|
NIA |
12/09/2019 |
01/16/2020
|
11/17/2022
|
R33
|
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) |
PA-20-067 |
See Related
|
AHRQ |
12/03/2019 |
11/29/2019
|
11/14/2022
|
K01
|
AHRQ Mentored Research Scientist Career Development Award (K01) |
PAR-20-066 |
See Related
|
NIGMS |
12/02/2019 |
01/21/2020
|
01/28/2022
|
R25
|
Postbaccalaureate Research Education Program (R25 - Independent Clinical Trial Not Allowed) |
PAR-20-064 |
See Related
|
NICHD |
11/25/2019 |
01/16/2020
|
01/08/2023
|
R03
|
Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed) |
PAR-20-065 |
See Related
|
NICHD |
11/25/2019 |
01/16/2020
|
01/08/2023
|
R03
|
Small Research Grants for Establishing Basic Science-Clinical Collaborations to Understand Structural Birth Defects (R03 Clinical Trial Not Allowed) |
PAR-20-063 |
See Related
|
NIAID |
11/22/2019 |
12/06/2019
|
01/08/2023
|
R24
|
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) |
PAR-20-061 |
See Related
|
NCI |
11/22/2019 |
02/17/2020
|
01/08/2023
|
R21
|
Co-infection and Cancer (R21 Clinical Trial Not Allowed) |
PAR-20-062 |
See Related
|
NCI |
11/22/2019 |
02/06/2020
|
01/08/2023
|
R01
|
Co-infection and Cancer (R01 Clinical Trial Not Allowed) |
PAR-20-044 |
See Related
|
NIDCR |
11/20/2019 |
08/25/2020
|
09/27/2022
|
T32
|
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T32 Clinical Trial Not Allowed) |
PAR-20-056 |
See Related
|
NIDCR |
11/20/2019 |
08/25/2020
|
09/27/2022
|
T90/R90
|
Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T90/R90 Clinical Trial Not Allowed) |
PAR-20-060 |
See Related
|
NIDCR |
11/19/2019 |
01/05/2020
|
01/10/2023
|
U01
|
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed) |
PAR-20-059 |
See Related
|
NIDCR |
11/18/2019 |
01/16/2020
|
01/08/2023
|
R21
|
Improving oral health and reducing disparities in adolescents (R21 Clinical Trial Not Allowed) |
PAR-20-058 |
See Related
|
NIDCR |
11/18/2019 |
01/05/2020
|
01/08/2023
|
R01
|
Improving oral health and reducing disparities in adolescents (R01 Clinical Trial Not Allowed) |
PAR-20-054 |
See Related
|
NIAID |
11/12/2019 |
04/10/2020
|
05/12/2021
|
R21
|
Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed) |
PAR-20-053 |
See Related
|
NCI |
11/12/2019 |
01/05/2020
|
01/08/2023
|
R01
|
Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed) |
PAR-20-051 |
See Related
|
NEI |
11/12/2019 |
08/30/2020
|
10/01/2022
|
P30
|
NEI Center Core Grant for Vision Research (P30 Clinical Trial Not Allowed) |
PAR-20-045 |
See Related
|
NIDCR |
11/08/2019 |
01/05/2020
|
01/08/2023
|
R01
|
NIDCR Research Grants for Analyses of Existing Genomics Data (R01 Clinical Trial Not Allowed) |
PAR-20-046 |
See Related
|
NIDCR |
11/08/2019 |
01/16/2020
|
01/08/2023
|
R03
|
NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed) |
PAR-20-052 |
See Related
|
NCI |
11/08/2019 |
12/07/2019
|
01/08/2023
|
R03
|
NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional) |
PAR-20-050 |
See Related
|
NINDS |
11/07/2019 |
01/12/2020
|
01/08/2023
|
K01
|
NINDS Postdoctoral Mentored Career Development Award (K01 Clinical Trial Required) |
PAR-20-049 |
See Related
|
NINDS |
11/07/2019 |
01/12/2020
|
01/08/2023
|
K01
|
NINDS Postdoctoral Mentored Career Development Award (K01 No Independent Clinical Trial Allowed) |
PAR-20-048 |
See Related
|
NIMHD |
11/06/2019 |
06/15/2020
|
07/16/2022
|
U24
|
Building Population Health Research Capacity in the U.S. Affiliated Pacific Islands (U24 Clinical Trial Not Allowed) |
PAR-20-043 |
See Related
|
NCI |
11/04/2019 |
12/25/2019
|
09/26/2022
|
P30
|
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) |
PAR-20-039 |
See Related
|
NIGMS |
10/24/2019 |
12/25/2019
|
05/08/2021
|
SC1
|
Support of Competitive Research (SCORE) Research Advancement Award (SC1 - Clinical Trial Not Allowed) |
PAR-20-040 |
See Related
|
NIGMS |
10/24/2019 |
12/25/2019
|
05/08/2021
|
SC2
|
Support of Competitive Research (SCORE) Pilot Project Award (SC2 - Clinical Trial Not Allowed) |
PAR-20-041 |
See Related
|
NIGMS |
10/24/2019 |
12/25/2019
|
05/08/2021
|
SC3
|
Support of Competitive Research (SCORE) Research Continuance Award (SC3 - Clinical Trial Not Allowed) |
PAR-20-036 |
See Related
|
NIAID |
10/24/2019 |
12/07/2019
|
09/08/2022
|
R01
|
Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Optional) |
PAR-20-042 |
See Related
|
NICHD |
10/24/2019 |
02/29/2020
|
04/01/2022
|
R03
|
NCMRR Early Career Research Award (R03 Clinical Trial Optional) |
PAR-20-035 |
See Related
|
NIDA |
10/18/2019 |
02/17/2020
|
11/08/2022
|
R61/R33
|
Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) |
PAR-19-394 |
See Related
|
NIA |
10/18/2019 |
01/16/2020
|
01/08/2023
|
R36
|
Aging Research Dissertation Awards to Increase Diversity (R36 Clinical Trial Not Allowed) |
PAR-20-034 |
See Related
|
NCI |
10/18/2019 |
01/05/2020
|
01/08/2023
|
R01
|
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) |
PAR-20-032 |
See Related
|
NICHD |
10/17/2019 |
11/20/2019
|
12/21/2021
|
R03
|
Human-Animal Interaction (HAI) Research (R03 Clinical Trial Optional) |
PAR-20-033 |
See Related
|
NICHD |
10/17/2019 |
11/20/2019
|
12/21/2021
|
R21
|
Human-Animal Interaction (HAI) Research (R21 Clinical Trial Optional) |
PAR-20-031 |
See Related
|
NICHD |
10/17/2019 |
11/20/2019
|
12/21/2021
|
R01
|
Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional) |
PAR-20-029 |
See Related
|
NIAID |
10/10/2019 |
12/06/2019
|
01/08/2022
|
R01
|
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical Trial Not Allowed) |
PA-20-028 |
See Related
|
AHRQ |
10/10/2019 |
10/04/2019
|
09/26/2022
|
R18
|
Medication Safety: Advancing the Development of Improvement Strategies and Tools (R18) |
PAS-19-391 |
See Related
|
NIA |
10/07/2019 |
01/16/2020
|
11/17/2022
|
R03
|
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Archiving and Leveraging Existing Data Sets for Analyses (R03 Clinical Trial Not Allowed) |
PAS-19-392 |
See Related
|
NIA |
10/07/2019 |
01/16/2020
|
11/17/2022
|
R03
|
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Basic Science (R03 Clinical Trials Not Allowed) |
PAS-19-393 |
See Related
|
NIA |
10/07/2019 |
01/16/2020
|
11/17/2022
|
R03
|
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research: Area of Focus Systems Biology (R03 Clinical Trial Not Allowed) |
PAR-20-027 |
See Related
|
NIMH |
10/02/2019 |
01/15/2020
|
09/16/2021
|
U01
|
Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (Collaborative U01 Clinical Trial Not Allowed) |
PAR-20-026 |
See Related
|
NIMH |
10/02/2019 |
01/15/2020
|
09/16/2022
|
U01
|
Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations (U01 Clinical Trial Not Allowed) |
PAR-19-387 |
See Related
|
NCI |
10/02/2019 |
01/05/2020
|
01/08/2023
|
R01
|
Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) |
PAR-19-389 |
See Related
|
NCI |
10/02/2019 |
01/16/2020
|
01/08/2023
|
R21
|
Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) |
PAR-19-385 |
See Related
|
NIEHS |
09/30/2019 |
11/10/2019
|
11/17/2021
|
R21
|
Environmental Risks for Psychiatric Disorders: Biological Basis of Pathophysiology (R21 Clinical Trial Not Allowed) |
PAR-19-386 |
See Related
|
NIEHS |
09/30/2019 |
11/10/2019
|
11/17/2021
|
R01
|
Environmental Risks for Psychiatric Disorders: Biological Basis of Pathophysiology (R01 Clinical Trial Not Allowed) |
PAR-19-380 |
See Related
|
NHGRI |
09/17/2019 |
12/24/2019
|
09/26/2022
|
R25
|
Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25) |
PAR-19-381 |
See Related
|
NINR |
09/17/2019 |
05/05/2020
|
05/08/2023
|
R01
|
Patient Activation for Self-Management of Chronic Conditions (R01 Clinical Trial Optional) |
PAR-19-382 |
See Related
|
NINR |
09/17/2019 |
05/16/2020
|
05/08/2023
|
R21
|
Patient Activation for Self-Management of Chronic Conditions (R21 Clinical Trial Optional) |
PAR-19-378 |
See Related
|
NIDDK |
09/16/2019 |
11/08/2019
|
09/08/2022
|
F31
|
Bioinformatics Interdisciplinary Predoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F31) |
PAR-19-379 |
See Related
|
NIDDK |
09/16/2019 |
11/08/2019
|
09/08/2022
|
F31
|
Bioinformatics Interdisciplinary Postdoctoral Fellowship in Diabetes, Endocrinology and Metabolic Diseases (F32) |
PAR-19-377 |
See Related
|
NINR |
09/13/2019 |
01/05/2020
|
01/08/2023
|
R01
|
Omics-guided Biobehavioral Interventions for Improved Health Outcomes: A Step Forward in Translation (R01 Clinical Trial Optional) |
PAR-19-374 |
See Related
|
NIA |
09/13/2019 |
12/25/2019
|
09/26/2022
|
U19
|
Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) |
PAR-19-375 |
See Related
|
NICHD |
09/12/2019 |
01/16/2020
|
01/08/2023
|
R03
|
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) |
PAR-19-372 |
See Related
|
NIMHD |
09/10/2019 |
10/06/2019
|
11/09/2022
|
R01
|
Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) |
PAR-19-371 |
See Related
|
NIAID |
09/09/2019 |
09/12/2019
|
01/08/2022
|
K22
|
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) |
PAR-19-365 |
See Related
|
NIDDK |
09/09/2019 |
09/16/2019
|
09/08/2022
|
R03
|
Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional) |
PAR-19-368 |
See Related
|
NIDA |
09/09/2019 |
09/05/2019
|
09/08/2021
|
R01
|
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) |
PAR-19-367 |
See Related
|
NIGMS |
09/09/2019 |
12/17/2019
|
05/18/2022
|
R35
|
Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) |
PAR-19-366 |
See Related
|
NIGMS |
09/09/2019 |
10/13/2019
|
10/02/2021
|
K12
|
Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed) |
PAR-19-363 |
See Related
|
NCI |
09/05/2019 |
09/05/2019
|
09/08/2021
|
R01
|
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
PAR-19-362 |
See Related
|
FIC |
09/03/2019 |
10/12/2019
|
10/29/2022
|
D71
|
Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed) |
PAR-19-357 |
See Related
|
NIAID |
09/03/2019 |
12/06/2019
|
01/11/2022
|
R01
|
Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed) |
PAR-19-364 |
See Related
|
NIAID |
09/03/2019 |
12/06/2019
|
01/11/2022
|
R21
|
Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed) |
PAR-19-361 |
See Related
|
NCI |
08/29/2019 |
10/12/2019
|
03/12/2022
|
U01
|
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed) |
PAR-19-358 |
See Related
|
NCI |
08/29/2019 |
09/16/2019
|
09/08/2022
|
R21
|
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) |
PAR-19-359 |
See Related
|
NCI |
08/29/2019 |
09/16/2019
|
07/17/2022
|
R03
|
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional) |
PAR-19-360 |
See Related
|
NCI |
08/29/2019 |
09/17/2019
|
09/08/2022
|
R01
|
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) |
PAR-19-355 |
See Related
|
NCI |
08/29/2019 |
09/16/2019
|
09/08/2022
|
R21
|
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional) |
PAR-19-352 |
See Related
|
NCI |
08/29/2019 |
09/17/2019
|
09/08/2022
|
R01
|
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) |
PAR-19-353 |
See Related
|
NCI |
08/28/2019 |
09/21/2019
|
05/28/2022
|
R01
|
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) |
PAR-19-354 |
See Related
|
NCI |
08/28/2019 |
09/21/2019
|
05/28/2022
|
R21
|
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) |
PAR-19-348 |
See Related
|
NCI |
08/16/2019 |
09/09/2019
|
06/09/2022
|
R01
|
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) |
PAR-19-350 |
See Related
|
NCI |
08/16/2019 |
09/09/2019
|
06/09/2022
|
R21
|
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) |
PAR-19-345 |
See Related
|
NIDA |
08/16/2019 |
09/08/2019
|
09/08/2022
|
P01
|
NIDA Program Project Grant Applications (P01 Clinical Trial Optional) |
PAR-19-343 |
See Related
|
NIGMS |
08/15/2019 |
01/12/2020
|
01/08/2023
|
K99/R00
|
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed) |
PAR-19-344 |
See Related
|
NIMH |
08/14/2019 |
02/10/2020
|
03/11/2022
|
R01
|
Explainable Artificial Intelligence for Decoding and Modulating Neural Circuit Activity Linked to Behavior (R01 Clinical Trial Optional) |
PAR-19-339 |
See Related
|
NCI |
08/12/2019 |
09/09/2019
|
06/09/2022
|
R21
|
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) |
PAR-19-340 |
See Related
|
NCI |
08/12/2019 |
09/09/2019
|
06/09/2022
|
R01
|
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) |
PAR-19-338 |
See Related
|
NIA |
08/09/2019 |
09/05/2019
|
07/06/2022
|
U01
|
Limited Competition: Renewals of, and Revisions and Resubmissions to, the Longitudinal Early-onset Alzheimers Disease Study (LEADS) Cooperative Agreement (U01 Clinical Trial Not Allowed) |
PAR-19-328 |
See Related
|
NHLBI |
08/05/2019 |
09/11/2019
|
09/09/2022
|
R61/R33
|
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required) |
PAR-19-330 |
See Related
|
NHLBI |
08/05/2019 |
09/11/2019
|
09/09/2022
|
U24
|
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) |
PAR-19-329 |
See Related
|
NHLBI |
08/05/2019 |
09/11/2019
|
09/09/2022
|
UG3/UH3
|
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) |
PAR-19-327 |
See Related
|
NIDA |
08/01/2019 |
07/26/2019
|
09/02/2022
|
U01
|
Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) |
PAR-19-321 |
See Related
|
NINR |
07/31/2019 |
09/05/2019
|
09/08/2022
|
R01
|
Palliative Care in Home and Community Settings (R01 Clinical Trial Optional) |
PAR-19-320 |
See Related
|
NINR |
07/31/2019 |
09/16/2019
|
09/08/2022
|
R21
|
Palliative Care in Home and Community Settings (R21 Clinical Trial Optional) |
PAR-19-325 |
See Related
|
NCI |
07/30/2019 |
08/30/2019
|
02/12/2022
|
R01
|
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
PAR-19-319 |
See Related
|
NIDDK |
07/29/2019 |
09/30/2019
|
06/29/2022
|
X01
|
NIDDK Central Repositories Non-renewable Sample Access (X01 Clinical Trial Not Allowed) |
PAR-19-318 |
See Related
|
NIDA |
07/25/2019 |
08/26/2019
|
09/02/2022
|
R01
|
Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01-Clinical Trial Optional) |
PAS-19-317 |
See Related
|
NIA |
07/18/2019 |
08/05/2019
|
09/07/2022
|
R41/R42
|
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) |
PAS-19-316 |
See Related
|
NIA |
07/18/2019 |
08/05/2019
|
09/07/2022
|
R43/R44
|
Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) |
PAR-19-314 |
See Related
|
NIA |
07/12/2019 |
08/09/2019
|
05/26/2022
|
P01
|
NIA Program Project Applications (P01 Clinical Trial Optional) |
PAR-19-315 |
See Related
|
NINDS |
07/10/2019 |
08/04/2019
|
05/08/2022
|
R61/R33
|
Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) |
PAR-19-313 |
See Related
|
NIGMS |
07/10/2019 |
12/28/2019
|
01/28/2022
|
P20
|
Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 - Clinical Trial Optional) |
PAR-19-312 |
See Related
|
NIGMS |
07/10/2019 |
08/30/2019
|
09/29/2021
|
P20
|
Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional) |
PAR-19-311 |
See Related
|
NIAAA |
07/10/2019 |
09/16/2019
|
01/08/2022
|
R21/R33
|
Mechanisms of Tolerance (R21/R33 - Clinical Trial Required) |
PAR-19-310 |
See Related
|
NIDA |
06/28/2019 |
09/16/2019
|
01/08/2022
|
R03
|
Behavioral Science Track Award for Rapid Transition (B/Start)(R03 Clinical Trial Optional) |
PAR-19-309 |
See Related
|
NCI |
06/28/2019 |
09/16/2019
|
09/08/2022
|
R21
|
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) |
PAR-19-306 |
See Related
|
FDA |
06/26/2019 |
08/01/2019
|
10/12/2022
|
R13
|
FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed) |
PAR-19-304 |
See Related
|
NIA |
06/25/2019 |
09/16/2019
|
07/17/2022
|
R33
|
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) |
PAR-19-305 |
See Related
|
NIA |
06/25/2019 |
09/16/2019
|
07/17/2022
|
R21/R33
|
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) |
PAR-19-302 |
See Related
|
NIA |
06/24/2019 |
09/05/2019
|
09/08/2022
|
R01
|
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) |
PAR-19-301 |
See Related
|
NIGMS |
06/24/2019 |
08/26/2019
|
06/16/2021
|
R24
|
Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) |
PAR-19-299 |
See Related
|
NIGMS |
06/17/2019 |
08/25/2019
|
09/28/2021
|
T34
|
National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate (T34) |
PAR-19-298 |
See Related
|
NIA |
06/14/2019 |
09/05/2019
|
09/08/2022
|
R01
|
Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) |
PAR-19-297 |
See Related
|
NIMH |
06/10/2019 |
06/29/2019
|
09/08/2022
|
R01
|
Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional) |
PAR-19-295 |
See Related
|
NIGMS |
06/07/2019 |
09/05/2019
|
01/08/2022
|
R01
|
Research to Understand and Inform Interventions that Promote the Research Careers of Individuals in the Biomedical Sciences (R01 - Clinical Trial Not Allowed) |
PAR-19-294 |
See Related
|
NIDDK |
06/06/2019 |
10/12/2019
|
11/13/2021
|
R01
|
Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed) |
PAR-19-292 |
See Related
|
NIDCR |
06/05/2019 |
09/05/2019
|
09/08/2022
|
R01
|
Mechanistic Studies of Gene-Environment Interplay in Dental, Oral, Craniofacial, and Other Diseases and Conditions (R01 Clinical Trial Not Allowed) |
PAR-19-293 |
See Related
|
NIDCR |
06/05/2019 |
09/16/2019
|
09/08/2022
|
R21
|
Development of Novel and Robust Systems for Mechanistic Studies of Gene-Environment Interplay in Dental, Oral, Craniofacial, and Other Diseases and Conditions (R21 Clinical Trial Not Allowed) |
PAR-19-289 |
See Related
|
NIMH |
05/29/2019 |
09/05/2019
|
09/08/2022
|
R01
|
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) |
PAR-19-288 |
See Related
|
NIA |
05/23/2019 |
08/25/2019
|
09/26/2022
|
U54
|
Limited Competition: NIA Genome Center for Alzheimer's Disease (U54 Clinical Trial Not Allowed) |
PAR-19-287 |
See Related
|
NCI |
05/22/2019 |
06/15/2019
|
11/16/2021
|
U01
|
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) |
PAR-19-286 |
See Related
|
NIGMS |
05/21/2019 |
09/02/2019
|
10/05/2021
|
FI2
|
Postdoctoral Research Associate Training (PRAT) Program (Fi2) |
PAR-19-282 |
See Related
|
NIDA |
05/15/2019 |
09/10/2019
|
05/08/2023
|
R61/R33
|
Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) |
PAR-19-285 |
See Related
|
FIC |
05/14/2019 |
07/20/2019
|
08/21/2021
|
G11
|
Infrastructure Development Training Programs for Critical HIV Research at Low-and Middle-Income Country Institutions (G11 Clinical Trials Not Allowed) |
PAR-19-283 |
See Related
|
FIC |
05/14/2019 |
07/20/2019
|
08/21/2021
|
D43
|
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) |
PAR-19-284 |
See Related
|
FIC |
05/14/2019 |
07/20/2019
|
08/21/2021
|
D71
|
Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed) |
PAR-19-278 |
See Related
|
NIDA |
05/08/2019 |
05/24/2019
|
12/18/2021
|
R21/R33
|
Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed) |
PAR-19-277 |
See Related
|
NCI |
05/08/2019 |
05/08/2019
|
10/09/2021
|
R21
|
Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) |
PAR-19-274 |
See Related
|
NCI |
05/08/2019 |
05/08/2019
|
05/08/2022
|
R01
|
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) |
PAR-19-275 |
See Related
|
NCI |
05/08/2019 |
05/16/2019
|
05/08/2022
|
R21
|
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) |
PAR-19-276 |
See Related
|
NCI |
05/08/2019 |
05/16/2019
|
05/08/2022
|
R03
|
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) |
PAR-19-269 |
See Related
|
NIA |
05/06/2019 |
09/05/2019
|
09/08/2022
|
U01
|
Cognitive Systems Analysis of Alzheimer's Disease Genetic and Phenotypic Data (U01 Clinical Trial Not Allowed) |
PAR-19-264 |
See Related
|
NCI |
05/01/2019 |
06/10/2019
|
12/11/2021
|
R01
|
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) |
PAR-19-261 |
See Related
|
NICHD |
04/26/2019 |
06/01/2019
|
12/14/2021
|
X01
|
Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed) |
PAR-19-260 |
See Related
|
NEI |
04/24/2019 |
05/16/2019
|
05/08/2022
|
R21
|
NEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed) |
PAR-19-258 |
See Related
|
NIDA |
04/24/2019 |
06/22/2019
|
08/11/2021
|
R25
|
NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) |
PAR-19-259 |
See Related
|
NIDA |
04/24/2019 |
08/25/2019
|
11/18/2021
|
P50
|
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) |
PAR-19-257 |
See Related
|
NIAMS |
04/17/2019 |
05/19/2019
|
02/23/2022
|
R03
|
Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03) |
PAR-19-256 |
See Related
|
NINR |
04/16/2019 |
09/04/2019
|
01/07/2022
|
R01
|
Limited Competition: Modular Budget Research Project Grant for NIH Nurse Scientist Scholars (R01 Clinical Trial Optional) |
PAR-19-253 |
See Related
|
NIGMS |
04/12/2019 |
05/05/2019
|
05/08/2022
|
R01
|
Focused Technology Research and Development (R01 - Clinical Trial Not Allowed) |
PAR-19-254 |
See Related
|
NIGMS |
04/12/2019 |
05/16/2019
|
05/08/2022
|
R21
|
Exploratory Research for Technology Development (R21 - Clinical Trial Not Allowed) |
PAR-19-251 |
See Related
|
NCI |
04/12/2019 |
06/02/2019
|
11/09/2021
|
R01
|
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional) |
PAR-19-252 |
See Related
|
NCI |
04/12/2019 |
06/02/2019
|
11/09/2021
|
R21
|
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional) |
PAR-19-247 |
See Related
|
NIAID |
04/11/2019 |
05/18/2019
|
06/19/2021
|
R21
|
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R21 Clinical Trial Not Allowed) |
PAR-19-248 |
See Related
|
NIAID |
04/11/2019 |
05/10/2019
|
06/11/2021
|
R01
|
Research Projects to Improve the Predictive Value of Animal Models in Recapitulating Human Immunity to Influenza Infection and Vaccination (R01 Clinical Trial Not Allowed) |
PAR-19-244 |
See Related
|
FIC |
04/09/2019 |
05/04/2019
|
06/05/2021
|
R25
|
International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed) |
PAR-19-243 |
See Related
|
FIC |
04/09/2019 |
05/04/2019
|
06/05/2021
|
D43
|
International Bioethics Research Training Program (D43 Clinical Trial Optional) |
PAR-19-242 |
See Related
|
NCI |
04/08/2019 |
05/18/2019
|
06/18/2021
|
K12
|
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) |
PAS-19-241 |
See Related
|
NIDDK |
04/05/2019 |
05/05/2019
|
05/08/2022
|
R01
|
Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional) |
PAR-19-240 |
See Related
|
NIDCR |
04/04/2019 |
09/16/2019
|
09/08/2022
|
R21
|
Clinical Research to Improve the Oral Health of Older Adults (R21 Clinical Trial Not Allowed) |
PAR-19-239 |
See Related
|
NIDCR |
04/04/2019 |
09/05/2019
|
09/07/2022
|
R01
|
Clinical Research to Improve the Oral Health of Older Adults (R01 Clinical Trial Not Allowed) |
PAR-19-238 |
See Related
|
NIDCR |
04/04/2019 |
05/12/2019
|
05/08/2022
|
K18
|
Short-term Mentored Career Enhancement Award in Dental, Oral and Craniofacial Research for Mid-Career and Senior Investigators (K18 Independent Clinical Trial Not Allowed) |
PA-19-237 |
See Related
|
NIAID |
04/03/2019 |
05/16/2019
|
05/08/2022
|
R21
|
Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed) |
PAR-19-236 |
See Related
|
NIMH |
04/02/2019 |
05/05/2019
|
05/08/2022
|
R01
|
Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required) |
PAR-19-235 |
See Related
|
NIMH |
04/02/2019 |
05/16/2019
|
05/08/2022
|
R34
|
Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required) |
PAR-19-234 |
See Related
|
NIA |
04/02/2019 |
05/05/2019
|
05/08/2022
|
U01
|
Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project (U01 Clinical Trial Not Allowed) |
PAR-19-232 |
See Related
|
NIGMS |
04/01/2019 |
09/08/2019
|
10/09/2021
|
P30
|
Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed) |
PAR-19-231 |
See Related
|
NEI |
03/29/2019 |
05/16/2019
|
05/08/2022
|
R34
|
NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) |
PA-19-230 |
See Related
|
NIA |
03/28/2019 |
05/05/2019
|
07/06/2022
|
U01
|
Pragmatic clinical trial on efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia (U01 Clinical Trial Required) |
PAR-19-228 |
See Related
|
NINDS |
03/22/2019 |
04/29/2019
|
05/27/2021
|
T32
|
Institutional Translational Research Training Program (T32) |
PAR-19-222 |
See Related
|
NIDDK |
03/18/2019 |
05/16/2019
|
09/08/2021
|
R21
|
Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional) |
PAR-19-220 |
See Related
|
NINDS |
03/13/2019 |
07/14/2019
|
02/17/2022
|
U01
|
Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed) |
PAR-19-215 |
See Related
|
NIBIB |
03/08/2019 |
04/30/2019
|
05/29/2021
|
R25
|
Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed) |
PAR-19-214 |
See Related
|
NIMH |
03/08/2019 |
05/20/2019
|
02/23/2022
|
UG3/UH3
|
Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) |
PAR-19-212 |
See Related
|
NIDA |
03/07/2019 |
06/23/2019
|
03/24/2022
|
R01
|
Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) |
PAR-19-213 |
See Related
|
NIDA |
03/07/2019 |
06/23/2019
|
03/24/2022
|
R34
|
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) |
PAR-19-207 |
See Related
|
NIAAA |
03/04/2019 |
04/25/2019
|
08/12/2022
|
R25
|
Alcohol and Other Substance Use Research Education Programs for Health Professionals (R25 Clinical Trial Not Allowed) |
PAR-19-209 |
See Related
|
NIAID |
03/04/2019 |
04/06/2019
|
05/07/2021
|
R01
|
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) |
PA-19-201 |
See Related
|
NCCIH |
02/28/2019 |
05/16/2019
|
05/08/2022
|
R21
|
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) |
PA-19-200 |
See Related
|
NCCIH |
02/28/2019 |
05/05/2019
|
05/08/2022
|
R01
|
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) |
PAR-19-204 |
See Related
|
NHGRI |
02/28/2019 |
04/20/2019
|
05/21/2021
|
RM1
|
Centers of Excellence in Genomic Science (RM1 Clinical Trials Optional) |
PAR-19-202 |
See Related
|
NIDDK |
02/27/2019 |
04/30/2019
|
11/03/2021
|
RC2
|
High impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional) |
PAR-19-199 |
See Related
|
NCI |
02/27/2019 |
05/10/2019
|
11/09/2021
|
R21
|
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) |
PAR-19-198 |
See Related
|
NCI |
02/27/2019 |
05/10/2019
|
11/09/2021
|
R01
|
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) |
PAR-19-197 |
See Related
|
NINDS |
02/25/2019 |
03/23/2019
|
05/08/2021
|
R25
|
Summer Research Education Experience Program (R25 Clinical Trial Not Allowed) |
PAR-19-194 |
See Related
|
NCI |
02/22/2019 |
05/16/2019
|
05/08/2022
|
R21
|
Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed) |
PAR-19-193 |
See Related
|
NCI |
02/22/2019 |
05/05/2019
|
05/08/2022
|
R01
|
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) |
PAR-19-189 |
See Related
|
NIMH |
02/21/2019 |
02/28/2019
|
01/08/2022
|
R34
|
Pilot Services Research Grants Not Involving Clinical Trials (R34 Clinical Trial Not Allowed) |
PAR-19-185 |
See Related
|
NHGRI |
02/12/2019 |
04/25/2019
|
01/26/2022
|
R25
|
Initiative to Maximize Research Education in Genomics: Courses (R25 Clinical Trial Not Allowed) |
PAR-19-184 |
See Related
|
NCI |
02/05/2019 |
05/16/2019
|
05/08/2022
|
R21
|
Biology of Bladder Cancer (R21 Clinical Trial Optional) |
PAR-19-183 |
See Related
|
NCI |
02/05/2019 |
05/05/2019
|
05/08/2022
|
R01
|
Biology of Bladder Cancer (R01 Clinical Trial Optional) |
PAR-19-176 |
See Related
|
ORIP |
01/29/2019 |
05/16/2019
|
05/08/2022
|
R21
|
Methods Development for Cryogenic or Other Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R21 Clinical Trial Not Allowed) |
PAR-19-173 |
See Related
|
NIDCR |
01/29/2019 |
05/16/2019
|
05/08/2022
|
R21
|
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed) |
PAR-19-172 |
See Related
|
NIDCR |
01/29/2019 |
05/05/2019
|
05/08/2022
|
R01
|
Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed) |
PAR-19-171 |
See Related
|
NINDS |
01/28/2019 |
02/27/2019
|
01/08/2022
|
UG3/UH3
|
Comparative Effectiveness Research in Clinical Neurosciences (UG3/UH3 Clinical Trial Not Allowed) |
PA-19-166 |
See Related
|
NHLBI |
01/22/2019 |
05/05/2019
|
05/08/2022
|
R01
|
Implementation of shared decision making for HLBS diseases and conditions (R01 Clinical Trial Optional) |
PAR-19-162 |
See Related
|
NIDA |
01/09/2019 |
05/05/2019
|
09/08/2021
|
R01
|
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) |
PAR-19-163 |
See Related
|
NIDA |
01/09/2019 |
05/16/2019
|
09/08/2021
|
R21
|
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) |
PAR-19-160 |
See Related
|
NIDCR |
01/08/2019 |
01/12/2019
|
01/08/2022
|
K01
|
NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Workforce (K01 Independent Clinical Trial Not Allowed) |
PAR-19-161 |
See Related
|
NIDCR |
01/08/2019 |
01/12/2019
|
01/08/2022
|
K01
|
NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Workforce (K01 Independent Basic Experimental Studies with Humans Required) |
PAR-19-152 |
See Related
|
NIDCR |
01/08/2019 |
01/12/2019
|
01/08/2022
|
K22
|
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Independent Clinical Trial Not Allowed) |
PAR-19-151 |
See Related
|
NIDCR |
01/08/2019 |
01/12/2019
|
01/08/2022
|
K22
|
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Independent Basic Experimental Studies with Humans Required) |
PAR-19-153 |
See Related
|
NINR |
01/08/2019 |
01/16/2019
|
01/08/2022
|
R21
|
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) |
PAR-19-156 |
See Related
|
NIBIB |
01/08/2019 |
01/08/2019
|
01/08/2022
|
U01
|
Bioengineering Research Partnerships (U01 Clinical Trial Not Allowed) |
PAR-19-157 |
See Related
|
NIBIB |
01/08/2019 |
01/08/2019
|
01/08/2022
|
U01
|
Bioengineering Research Partnerships (U01 Clinical Trial Required) |
PAR-19-149 |
See Related
|
NCI |
01/08/2019 |
01/16/2019
|
01/08/2022
|
R21
|
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) |
PAR-19-150 |
See Related
|
NCI |
01/08/2019 |
01/16/2019
|
01/08/2022
|
R21
|
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) |
PAR-19-158 |
See Related
|
NIBIB |
01/08/2019 |
01/08/2019
|
01/08/2022
|
R01
|
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) |
PAR-19-159 |
See Related
|
NIBIB |
01/08/2019 |
01/08/2019
|
05/08/2022
|
R01
|
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) |
PAR-19-146 |
See Related
|
NIMH |
01/08/2019 |
01/16/2019
|
01/08/2022
|
R21
|
Drug Discovery For Nervous System Disorders (R21 Clinical Trial Not Allowed) |
PAR-19-147 |
See Related
|
NIMH |
01/08/2019 |
01/16/2019
|
01/08/2022
|
R01
|
Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) |
PAR-19-145 |
See Related
|
NIDCR |
01/08/2019 |
01/16/2019
|
01/08/2022
|
R03
|
NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed) |
PAR-19-141 |
See Related
|
NIDCR |
12/28/2018 |
01/12/2019
|
01/08/2022
|
K99/R00
|
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Basic Experimental Studies with Humans Required) |
PAR-19-144 |
See Related
|
NIDCR |
12/28/2018 |
01/12/2019
|
01/08/2022
|
K99/R00
|
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed) |
PAR-19-137 |
See Related
|
NIDCD |
12/26/2018 |
01/07/2019
|
10/07/2021
|
P50
|
NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional) |
PAR-19-135 |
See Related
|
NINR |
12/21/2018 |
01/25/2019
|
01/08/2022
|
R15
|
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) |
PAR-19-134 |
See Related
|
NIDCR |
12/21/2018 |
01/25/2019
|
01/08/2022
|
R15
|
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) |
PAR-19-136 |
See Related
|
NINR |
12/21/2018 |
01/05/2019
|
01/08/2022
|
R01
|
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) |
PAR-19-133 |
See Related
|
NICHD |
12/21/2018 |
01/25/2019
|
01/08/2022
|
R15
|
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required) |
PA-19-112 |
See Related
|
NCI |
12/17/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) |
PA-19-111 |
See Related
|
NCI |
12/17/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) |
PAR-19-113 |
See Related
|
NCI |
12/17/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) |
PAS-19-105 |
See Related
|
NIDDK |
12/17/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) |
PAR-19-100 |
See Related
|
NCATS |
12/12/2018 |
02/08/2019
|
11/10/2021
|
R21
|
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional) |
PAR-19-099 |
See Related
|
NCATS |
12/12/2018 |
02/08/2019
|
11/10/2021
|
U01
|
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award, (U01 Clinical Trial Optional) |
PA-19-096 |
See Related
|
NIAID |
11/29/2018 |
01/04/2019
|
01/08/2022
|
R01
|
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed) |
PA-19-094 |
See Related
|
NIMH |
11/29/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Emotion Regulation, Aging and Mental Disorder (R01 Clinical Trial Not Allowed) |
PA-19-095 |
See Related
|
NIMH |
11/29/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Emotion Regulation, Aging and Mental Disorder (R21 Clinical Trial Not Allowed) |
PA-19-082 |
See Related
|
NIAID |
11/26/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed) |
PA-19-083 |
See Related
|
NIAID |
11/26/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed) |
PA-19-081 |
See Related
|
NIAID |
11/26/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed) |
PA-19-080 |
See Related
|
NIAID |
11/26/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed) |
PA-19-077 |
See Related
|
NIAID |
11/26/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed) |
PA-19-075 |
See Related
|
NIDCR |
11/26/2018 |
03/05/2019
|
01/06/2022
|
R41/R42
|
Enabling Technologies to Accelerate Development of Oral Biodevices (R41/R42 Clinical Trial Not Allowed) |
PA-19-076 |
See Related
|
NIDCR |
11/26/2018 |
03/05/2019
|
01/06/2022
|
R43/R44
|
Enabling Technologies to Accelerate Development of Oral Biodevices (R43/R44 Clinical Trial Not Allowed) |
PAR-19-079 |
See Related
|
NIAID |
11/26/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) |
PAR-19-078 |
See Related
|
NIAID |
11/26/2018 |
01/04/2019
|
01/08/2022
|
R01
|
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) |
PA-19-074 |
See Related
|
NINR |
11/20/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Telomeres in Wellness and Disease: A Biobehavioral Approach (R01 Clinical Trial Optional) |
PA-19-073 |
See Related
|
NINR |
11/20/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Telomeres in Wellness and Disease: A Biobehavioral Approach (R21 Clinical Trial Optional) |
PAR-19-072 |
See Related
|
NLM |
11/19/2018 |
12/18/2018
|
07/31/2021
|
R01
|
Data Science Research: Personal Health Libraries for Consumers and Patients (R01 Clinical Trial Optional) |
PAR-19-070 |
See Related
|
NIA |
11/16/2018 |
02/11/2019
|
11/13/2021
|
R01
|
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) |
PAR-19-071 |
See Related
|
NIA |
11/16/2018 |
02/11/2019
|
11/13/2021
|
R21
|
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) |
PA-19-065 |
See Related
|
NIDDK |
11/13/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Medical Simulators for Practicing Patient Care Providers Skill Acquisition, Outcomes Assessment and Technology Development (R01 Clinical Trial Not Allowed) |
PA-19-066 |
See Related
|
NIAID |
11/13/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed) |
PA-19-067 |
See Related
|
NIAID |
11/13/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed) |
PAR-19-064 |
See Related
|
NIDA |
11/09/2018 |
01/08/2019
|
10/09/2021
|
R21
|
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) |
PAR-19-061 |
See Related
|
NHGRI |
11/08/2018 |
12/05/2018
|
09/06/2021
|
R43/R44
|
Investigator Initiated Research in Computational Genomics and Data Science (R43/R44 Clinical Trial Not Allowed) |
PAR-19-058 |
See Related
|
NINR |
11/07/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R21 Clinical Trial Optional) |
PAR-19-057 |
See Related
|
NINR |
11/07/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Strategies to Provide Culturally Tailored Palliative and End-of-Life Care for Seriously Ill American Indian and Alaska Native Individuals (R01 Clinical Trial Optional) |
PA-19-050 |
See Related
|
NIAID |
11/01/2018 |
12/07/2018
|
09/08/2021
|
R21
|
Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional) |
PA-19-042 |
See Related
|
NIAID |
11/01/2018 |
12/07/2018
|
09/08/2021
|
R01
|
Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional) |
PA-19-049 |
See Related
|
NHLBI |
11/01/2018 |
01/16/2019
|
01/08/2022
|
R21
|
New Research Directions that Advance the NHLBI Strategic Vision Normal Biology (R21 - Clinical Trial Not Allowed) |
PA-19-043 |
See Related
|
NHGRI |
10/31/2018 |
12/05/2018
|
09/06/2021
|
R43/R44
|
Novel Approaches for Relating Genetic Variation to Function and Disease (R43/R44 Clinical Trial Not Allowed) |
PA-19-046 |
See Related
|
NIDCD |
10/31/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Advancing Research in Augmentative and Alternative Communication (AAC) (R21 Clinical Trial Optional) |
PA-19-047 |
See Related
|
NIDCD |
10/31/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Advancing Research in Augmentative and Alternative Communication (AAC) (R01 Clinical Trial Optional) |
PAR-19-045 |
See Related
|
NINR |
10/31/2018 |
01/05/2019
|
01/08/2022
|
R01
|
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R01 Clinical Trial Optional) |
PAR-19-044 |
See Related
|
NINR |
10/31/2018 |
01/16/2019
|
01/08/2022
|
R21
|
End-of-Life and Palliative Care Approaches to Advanced Signs and Symptoms (R21- Clinical Trial Optional) |
PAR-19-039 |
See Related
|
NINDS |
10/26/2018 |
08/10/2019
|
09/15/2021
|
U01
|
Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed) |
PAR-19-040 |
See Related
|
NINDS |
10/26/2018 |
08/10/2019
|
09/15/2021
|
U01
|
Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional) |
PA-19-034 |
See Related
|
NIDCR |
10/24/2018 |
12/05/2018
|
09/06/2021
|
R43/R44
|
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed) |
PA-19-033 |
See Related
|
NIDCR |
10/24/2018 |
12/05/2018
|
09/06/2021
|
R41/R42
|
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed) |
PA-19-031 |
See Related
|
NCCIH |
10/18/2018 |
03/01/2019
|
10/02/2021
|
|
Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supp Clinical Trial Optional) |
PAR-19-027 |
See Related
|
NIMH |
10/17/2018 |
01/04/2019
|
01/08/2022
|
R01
|
Basic Neurodevelopmental Biology of Circuits and Behavior (R01 Clinical Trial Not Allowed) |
PAR-19-028 |
See Related
|
NIMH |
10/17/2018 |
01/04/2019
|
01/08/2022
|
R21
|
Basic Neurodevelopmental Biology of Brain Circuits and Behavior (R21 Clinical Trial Not Allowed) |
PA-19-023 |
See Related
|
NINR |
10/12/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Addressing Caregiver Symptoms through Technological Tools (R01 Clinical Trial Optional) |
PA-19-024 |
See Related
|
NINR |
10/12/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Addressing Caregiver Symptoms through Technological Tools (R21 Clinical Trial Optional) |
PA-19-021 |
See Related
|
NIDCR |
10/09/2018 |
12/05/2018
|
09/06/2021
|
R41/R42
|
Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R41/R42 Clinical Trial Not Allowed) |
PA-19-022 |
See Related
|
NIDCR |
10/09/2018 |
12/05/2018
|
09/06/2021
|
R43/R44
|
Advancing Imaging, Device Production, and Clinical Capabilities in Digital Dentistry (R43/R44 Clinical Trial Not Allowed) |
PA-19-020 |
See Related
|
NIAID |
10/05/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed) |
PAR-18-952 |
See Related
|
NCATS |
10/04/2018 |
12/07/2018
|
10/26/2021
|
R03
|
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed) |
PAR-18-953 |
See Related
|
NCATS |
10/04/2018 |
12/07/2018
|
10/26/2021
|
R21
|
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) |
PA-18-935 |
See Related
|
NIH |
10/03/2018 |
09/24/2018
|
01/25/2022
|
|
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) |
PA-18-943 |
See Related
|
NINR |
10/01/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) |
PA-18-944 |
See Related
|
NINR |
10/01/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) |
PA-18-946 |
See Related
|
NINR |
10/01/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional) |
PA-18-945 |
See Related
|
NINR |
10/01/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) |
PAR-18-947 |
See Related
|
NCI |
09/28/2018 |
10/28/2018
|
07/12/2021
|
U01
|
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) |
PAR-18-942 |
See Related
|
NIMH |
09/27/2018 |
10/27/2018
|
09/08/2021
|
R01
|
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional) |
PAR-18-941 |
See Related
|
NIMH |
09/27/2018 |
10/27/2018
|
09/08/2021
|
R21
|
Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional) |
PAR-18-940 |
See Related
|
NCATS |
09/27/2018 |
12/25/2018
|
07/16/2021
|
U54
|
Clinical and Translational Science Award (U54 Clinical Trial Optional) |
PA-18-937 |
See Related
|
NINDS |
09/26/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional) |
PA-18-939 |
See Related
|
NINDS |
09/26/2018 |
01/16/2019
|
01/08/2022
|
R21
|
Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed) |
PA-18-932 |
See Related
|
ODP |
09/21/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) |
PAR-18-929 |
See Related
|
NIMH |
09/21/2018 |
10/21/2018
|
09/08/2021
|
R01
|
High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not Allowed) |
PAR-18-930 |
See Related
|
NIMH |
09/21/2018 |
01/05/2019
|
01/08/2022
|
R01
|
Development and Optimization of Tasks and Measures for Functional Domains of Behavior (R01 Clinical Trial Not Allowed) |
PA-18-928 |
See Related
|
NIMH |
09/19/2018 |
12/05/2018
|
09/06/2021
|
R43/R44
|
Innovative Technologies for HIV Behavioral and Social Science Research (R43/R44 Clinical Trial Optional) |
PA-18-927 |
See Related
|
NIMH |
09/19/2018 |
12/05/2018
|
09/06/2021
|
R41/R42
|
Innovative Technologies for HIV Behavioral and Social Science Research (R41/R42 Clinical Trial Optional) |
PA-18-926 |
See Related
|
NIAID |
09/18/2018 |
09/18/2018
|
09/10/2021
|
|
Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp) |
PAR-18-918 |
See Related
|
NIDA |
09/10/2018 |
09/16/2018
|
09/08/2021
|
R03
|
Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional) |
PA-18-917 |
See Related
|
NIDA |
09/10/2018 |
09/24/2018
|
09/08/2021
|
R01
|
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional) |
PA-18-916 |
See Related
|
NIDA |
09/10/2018 |
12/07/2018
|
09/08/2021
|
R03
|
AIDS-Science Track Award for Research Transition (R03 Clinical Trial Optional) |
PAS-18-915 |
See Related
|
NIDA |
09/10/2018 |
12/07/2018
|
09/08/2021
|
R01
|
HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional) |
PAR-18-913 |
See Related
|
NCI |
09/07/2018 |
01/11/2019
|
08/12/2021
|
U01
|
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) |
PAR-18-910 |
See Related
|
NCATS |
08/31/2018 |
04/03/2019
|
05/04/2021
|
U01
|
Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01) (Clinical Trial Required) |
PA-18-908 |
See Related
|
NIMH |
08/29/2018 |
01/05/2019
|
01/08/2022
|
R01
|
New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 Clinical Trial Not Allowed) |
PA-18-907 |
See Related
|
NIMH |
08/29/2018 |
01/05/2019
|
01/08/2022
|
R01
|
New Computational Methods for Understanding the Functional Role of DNA Variants that are Associated with Mental Disorders (R01 (Collab) Clinical Trial Not Allowed) |
PAR-18-904 |
See Related
|
NIMH |
08/16/2018 |
10/08/2018
|
09/08/2021
|
R01
|
Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 Clinical Trial Not Allowed) |
PAR-18-905 |
See Related
|
NIMH |
08/16/2018 |
10/08/2018
|
09/08/2021
|
R01
|
Leveraging Electronic Medical Records for Psychiatric Genetic Research (R01 (Collab) Clinical Trial Not Allowed) |
PA-18-902 |
See Related
|
NCI |
08/14/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) |
PAR-18-896 |
See Related
|
NLM |
08/09/2018 |
09/05/2018
|
09/08/2021
|
R01
|
NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional) |
PAR-18-898 |
See Related
|
NIDDK |
08/09/2018 |
10/01/2018
|
06/02/2021
|
RC2
|
Elucidating the Role of the Autonomic Nervous System in Peripheral Metabolism and Metabolic Disease through the Application of Novel Tools and Methodologies (RC2 Clinical Trial Optional) |
PAR-18-894 |
See Related
|
NIMH |
08/08/2018 |
11/06/2018
|
09/08/2022
|
R36
|
Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) |
PAR-18-892 |
See Related
|
NCI |
08/07/2018 |
09/16/2018
|
09/08/2021
|
R21
|
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) |
PAR-18-893 |
See Related
|
NCI |
08/07/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) |
PAR-18-890 |
See Related
|
NIA |
08/03/2018 |
09/05/2018
|
09/08/2021
|
U01
|
Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project: Opportunity for Revision Requests for Active Cooperative Agreements (U01 Clinical Trial Not Allowed) |
PAR-18-889 |
See Related
|
NIA |
08/03/2018 |
09/05/2018
|
09/08/2021
|
U01
|
Limited Competition: Renewal of, and Revisions to, the Alzheimer's Disease Genetics Consortium (U01 Clinical Trial Not Allowed) |
PAR-18-886 |
See Related
|
NIDDK |
08/02/2018 |
10/01/2018
|
06/02/2021
|
RC2
|
New Paradigms in Tissue Communication-from mediators to metabolic function (RC2 Clinical Trials Optional) |
PAR-18-885 |
See Related
|
NICHD |
08/01/2018 |
11/04/2018
|
12/07/2021
|
R21
|
Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R21 - Clinical Trial Not Allowed) |
PAR-18-884 |
See Related
|
NICHD |
08/01/2018 |
11/04/2018
|
12/07/2021
|
R01
|
Novel Approaches to Safe, Non-Invasive, Real Time Assessment of Human Placenta Development and Function Across Pregnancy (R01 - Clinical Trial Not Allowed) |
PAR-18-878 |
See Related
|
NIA |
07/26/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) |
PAR-18-877 |
See Related
|
NIA |
07/26/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Early Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) |
PA-18-876 |
See Related
|
NIDCR |
07/25/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed) |
PA-18-874 |
See Related
|
NIDCR |
07/25/2018 |
09/16/2018
|
09/08/2021
|
R21
|
Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed) |
PAR-18-875 |
See Related
|
NIDCR |
07/25/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R01 - Clinical Trial Not Allowed) |
PA-18-873 |
See Related
|
NIAID |
07/24/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed) |
PA-18-872 |
See Related
|
NIAID |
07/24/2018 |
09/16/2018
|
09/08/2021
|
R21
|
Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed) |
PA-18-871 |
See Related
|
NIMH |
07/24/2018 |
08/05/2018
|
05/07/2021
|
R43/R44
|
BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (SBIR) (R43/R44 - Clinical Trial Not Allowed) |
PA-18-870 |
See Related
|
NIMH |
07/24/2018 |
08/05/2018
|
05/07/2021
|
R41/R42
|
BRAIN Initiative: Development Optimization, and Validation of Novel Tools and Technologies for Neuroscience Research (STTR) (R41/R42 - Clinical Trials Not Allowed) |
PA-18-867 |
See Related
|
NHGRI |
07/23/2018 |
09/16/2018
|
07/17/2021
|
R21
|
Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Trial Not Allowed) |
PA-18-868 |
See Related
|
NHGRI |
07/23/2018 |
09/05/2018
|
07/06/2021
|
R01
|
Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Trial Not Allowed) |
PAR-18-864 |
See Related
|
NEI |
07/19/2018 |
08/25/2018
|
09/08/2021
|
UG1
|
NEI Vision Research Epidemiology Grant (UG1 Clinical Trial Not Allowed) |
PA-18-863 |
See Related
|
NIAAA |
07/19/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01 - Clinical Trial Optional) |
PA-18-861 |
See Related
|
NIAAA |
07/19/2018 |
09/05/2018
|
01/08/2022
|
R03
|
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R03 - Clinical Trial Optional) |
PA-18-862 |
See Related
|
NIAAA |
07/19/2018 |
09/16/2018
|
09/08/2021
|
R21
|
Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21 - Clinical Trial Optional) |
PA-18-859 |
See Related
|
NIAID |
07/18/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed) |
PA-18-858 |
See Related
|
NIAID |
07/18/2018 |
09/16/2018
|
09/08/2021
|
R21
|
Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed) |
PAR-18-857 |
See Related
|
NIDDK |
07/17/2018 |
09/16/2018
|
09/08/2021
|
R21
|
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) |
PA-18-856 |
See Related
|
NIDDK |
07/17/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) |
PAR-18-854 |
See Related
|
NIDDK |
07/12/2018 |
07/23/2018
|
09/11/2021
|
R01
|
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) |
PA-18-849 |
See Related
|
NINR |
07/05/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional) |
PA-18-850 |
See Related
|
NINR |
07/05/2018 |
09/16/2018
|
09/08/2021
|
R21
|
Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional) |
PAR-18-845 |
See Related
|
ODP |
06/29/2018 |
09/24/2018
|
06/16/2021
|
R01
|
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) |
PAR-18-846 |
See Related
|
ODP |
06/29/2018 |
09/24/2018
|
06/26/2021
|
R21
|
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) |
PAR-18-847 |
See Related
|
ODP |
06/29/2018 |
09/24/2018
|
06/16/2021
|
R01
|
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional) |
PAR-18-848 |
See Related
|
ODP |
06/29/2018 |
09/24/2018
|
06/26/2021
|
R21
|
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional) |
PAR-18-844 |
See Related
|
NHGRI |
06/28/2018 |
10/16/2018
|
09/08/2021
|
R01
|
Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) |
PAR-18-843 |
See Related
|
NHGRI |
06/28/2018 |
10/16/2018
|
09/08/2021
|
R21
|
Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) |
PAR-18-841 |
See Related
|
NCI |
06/28/2018 |
10/19/2018
|
06/15/2021
|
U24
|
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional) |
PA-18-838 |
See Related
|
NICHD |
06/26/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R01 - Clinical Trial Optional) |
PA-18-839 |
See Related
|
NICHD |
06/26/2018 |
09/16/2018
|
09/08/2021
|
R21
|
Role of Gut Microbiome in Regulating Reproduction and Its Impact on Fertility Status in Women Living with and Without HIV (R21 Clinical Trial Optional) |
PA-18-837 |
See Related
|
OD |
06/20/2018 |
06/20/2018
|
09/05/2021
|
|
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) |
PAR-18-831 |
See Related
|
NICHD |
06/14/2018 |
10/07/2018
|
06/04/2021
|
R21
|
The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed) |
PAR-18-830 |
See Related
|
NICHD |
06/14/2018 |
10/07/2018
|
06/04/2021
|
R01
|
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed) |
PA-18-825 |
See Related
|
NIA |
06/08/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Analyses of Adherence Strategies and Data Sets from CALERIE to Explore Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R01 - Clinical Trial Not Allowed) |
PA-18-826 |
See Related
|
NIA |
06/08/2018 |
09/16/2018
|
09/08/2021
|
R21
|
Exploratory Analyses of Adherence Strategies and Data Sets from CALERIE to Investigate Behavioral and Psychosocial Aspects of Sustained Caloric Restriction in Humans (R21 - Clinical Trial Not Allowed) |
PA-18-824 |
See Related
|
NIA |
06/08/2018 |
09/16/2018
|
09/08/2021
|
R21
|
Exploratory Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R21 - Clinical Trial Not Allowed) |
PA-18-823 |
See Related
|
NIA |
06/08/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Analyses of CALERIE Data and Biospecimens to Elucidate Mechanisms of Caloric Restriction (CR)-Induced Effects in Humans (R01 - Clinical Trial Not Allowed) |
PAR-18-820 |
See Related
|
NIA |
06/07/2018 |
09/05/2018
|
01/08/2022
|
U01
|
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) |
PAR-18-812 |
See Related
|
CDC |
05/30/2018 |
05/25/2018
|
11/18/2023
|
R01
|
Occupational Safety and Health Research (R01) |
PAR-18-798 |
See Related
|
NIOSH |
05/24/2018 |
05/24/2018
|
11/18/2023
|
R21
|
NIOSH Exploratory/Developmental Grant Program (R21) |
PAR-18-799 |
See Related
|
CDC |
05/24/2018 |
05/24/2018
|
11/18/2023
|
K01
|
K01 Mentored Research Scientist Development Award |
PAR-18-797 |
See Related
|
CDC |
05/24/2018 |
05/24/2018
|
11/18/2023
|
R03
|
NIOSH Small Research Grant Program |
PA-18-794 |
See Related
|
AHRQ |
05/21/2018 |
09/17/2018
|
07/07/2022
|
R03
|
AHRQ Small Research Grant Program (R03) |
PA-18-793 |
See Related
|
AHRQ |
05/21/2018 |
08/24/2018
|
09/30/2022
|
R18
|
AHRQ Health Services Research Demonstration and Dissemination Grants (R18) |
PA-18-795 |
See Related
|
AHRQ |
05/21/2018 |
09/05/2018
|
07/07/2022
|
R01
|
AHRQ Health Services Research Projects (R01) |
PA-18-791 |
See Related
|
NICHD |
05/21/2018 |
09/16/2018
|
09/08/2021
|
R03
|
Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R03 - Clinical Trial Optional) |
PA-18-790 |
See Related
|
NICHD |
05/21/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R01 - Clinical Trial Optional) |
PAR-18-788 |
See Related
|
NIDCR |
05/16/2018 |
09/16/2018
|
09/08/2021
|
R21
|
Precision Imaging of Oral Lesions (R21-Clinical Trial Not Allowed) |
PAR-18-787 |
See Related
|
NIDCR |
05/16/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed) |
PA-18-784 |
See Related
|
NHLBI |
05/15/2018 |
09/05/2018
|
09/08/2021
|
R01
|
The Mechanistic Role of the Microbiome in the Pathobiology of Heart, Lung, Blood, and Sleep Diseases (R01 - Clinical Trial Not Allowed) |
PA-18-780 |
See Related
|
NIDA |
05/10/2018 |
08/07/2018
|
05/08/2021
|
R34
|
Development and Testing of Novel Interventions to Improve HIV Prevention, Care, and Program Implementation (R34 - Clinical Trial Optional) |
PA-18-773 |
See Related
|
NIDA |
05/09/2018 |
05/09/2018
|
05/08/2021
|
R01
|
International Research Collaboration on Drug Abuse and Addiction Research (R01 Clinical Trial Optional) |
PA-18-776 |
See Related
|
NINR |
05/09/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional) |
PA-18-774 |
See Related
|
NIDA |
05/09/2018 |
05/16/2018
|
05/08/2021
|
R34
|
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) |
PAR-18-771 |
See Related
|
NHLBI |
05/09/2018 |
05/12/2018
|
05/08/2021
|
K22
|
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required) |
PAR-18-772 |
See Related
|
NHLBI |
05/09/2018 |
05/12/2018
|
05/08/2021
|
K22
|
NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed) |
PA-18-765 |
See Related
|
AHRQ |
05/02/2018 |
07/30/2018
|
05/02/2023
|
R36
|
AHRQ Health Services Research Dissertation Program (R36) |
PAR-18-766 |
See Related
|
NICHD |
04/27/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Identification and Management of Behavioral Symptoms and Mental Health Conditions in Individuals with Intellectual Disabilities (R01 - Clinical Trial Optional) |
PAR-18-764 |
See Related
|
NIAID |
04/20/2018 |
08/07/2018
|
05/08/2021
|
R01
|
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional) |
PAR-18-755 |
See Related
|
NIMH |
04/11/2018 |
05/12/2018
|
05/08/2021
|
K22
|
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 No Independent Clinical Trials) |
PA-18-753 |
See Related
|
NIAID |
04/11/2018 |
08/07/2018
|
05/08/2021
|
R01
|
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional) |
PA-18-754 |
See Related
|
NIAID |
04/11/2018 |
08/07/2018
|
05/08/2021
|
R21
|
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trials Not Allowed) |
PA-18-750 |
See Related
|
AHRQ |
04/10/2018 |
09/25/2018
|
09/08/2021
|
R18
|
Making Health Care Safer in Ambulatory Care Settings and Long Term Care Facilities (R18) |
PA-18-741 |
See Related
|
NIDDK |
04/03/2018 |
05/16/2018
|
05/08/2021
|
R21
|
Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed) |
PA-18-738 |
See Related
|
NCI |
04/03/2018 |
05/05/2018
|
05/08/2021
|
R01
|
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional). |
PA-18-739 |
See Related
|
NCI |
04/03/2018 |
05/16/2018
|
05/08/2021
|
R21
|
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional). |
PAS-18-730 |
See Related
|
NIDDK |
03/29/2018 |
05/05/2018
|
05/08/2021
|
R01
|
New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional) |
PA-18-718 |
See Related
|
NIAMS |
03/28/2018 |
09/16/2018
|
09/08/2021
|
R21
|
Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R21 Clinical Trial Not Allowed) |
PA-18-719 |
See Related
|
NIAMS |
03/28/2018 |
09/05/2018
|
09/08/2021
|
R01
|
Accelerating Basic and Translational Research in Hidradenitis Suppurativa (R01 Clinical Trial Not Allowed) |
PA-18-724 |
See Related
|
NIAID |
03/28/2018 |
05/16/2018
|
05/08/2021
|
R21
|
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed) |
PA-18-725 |
See Related
|
NIAID |
03/28/2018 |
05/05/2018
|
05/08/2021
|
R01
|
Generating New insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed) |
PA-18-722 |
See Related
|
OBSSR |
03/28/2018 |
05/05/2018
|
05/08/2021
|
R01
|
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) |
PA-18-723 |
See Related
|
OBSSR |
03/28/2018 |
05/16/2018
|
05/08/2021
|
R21
|
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) |
PAR-18-715 |
See Related
|
NIA |
03/21/2018 |
05/05/2018
|
05/08/2021
|
U01
|
NIA Limited Competition: Renewals of, and Revisions to, Existing Alzheimer's Disease Patient Registry Cooperative Agreement Awards (U01 - Clinical Trial Not Allowed) |
PA-18-708 |
See Related
|
NIMH |
03/15/2018 |
08/05/2018
|
09/06/2021
|
R43/R44
|
Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clinical Trial Not Allowed) |
PA-18-709 |
See Related
|
NIMH |
03/15/2018 |
08/05/2018
|
09/06/2021
|
R41/R42
|
Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R41/R42)-Clinical Trial Not Allowed |
PAR-18-712 |
See Related
|
NIAID |
03/15/2018 |
05/05/2018
|
05/08/2021
|
R01
|
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) |
PAR-18-710 |
See Related
|
NINDS |
03/15/2018 |
05/12/2018
|
07/13/2021
|
K22
|
Career Transition Award for NINDS Intramural Clinician-Scientists (K22) - Clinical Trial Required |
PAR-18-711 |
See Related
|
NINDS |
03/15/2018 |
05/12/2018
|
07/13/2021
|
K22
|
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) |
PAR-18-714 |
See Related
|
NIGMS |
03/14/2018 |
05/25/2018
|
05/08/2021
|
R15
|
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
PA-18-705 |
See Related
|
NINDS |
03/06/2018 |
08/05/2018
|
09/06/2021
|
R43/R44
|
SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed) |
PA-18-687 |
See Related
|
NICHD |
03/01/2018 |
05/16/2018
|
05/08/2021
|
R03
|
Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R03 Clinical Trial Optional) |
PA-18-688 |
See Related
|
NICHD |
03/01/2018 |
05/05/2018
|
05/08/2021
|
R01
|
Developmental Pharmacodynamics and Models of Drug Effects in Pediatrics (R01 Clinical Trial Optional) |
PAR-18-689 |
See Related
|
NICHD |
03/01/2018 |
05/05/2018
|
05/08/2021
|
R01
|
Innovative Therapies and Tools for Screenable Disorders (R01 Clinical Trial Optional) |
PAR-18-690 |
See Related
|
NICHD |
03/01/2018 |
05/16/2018
|
05/08/2021
|
R03
|
Innovative Therapies and Tools for Screenable Disorders (R03 Clinical Trial Optional) |
PAR-18-691 |
See Related
|
NICHD |
03/01/2018 |
05/16/2018
|
05/08/2021
|
R21
|
Innovative Therapies and Tools for Screenable Disorders (R21 Clinical Trial Optional) |
PA-18-678 |
See Related
|
NCI |
02/23/2018 |
05/16/2018
|
05/08/2021
|
R21
|
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed) |
PA-18-677 |
See Related
|
NCI |
02/23/2018 |
05/05/2018
|
05/08/2021
|
R01
|
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed) |
PA-18-660 |
See Related
|
NIAAA |
02/14/2018 |
05/05/2018
|
05/08/2021
|
R01
|
Genetics of Alcohol Sensitivity and Tolerance (R01 Clinical Trial Not Allowed) |
PAR-18-659 |
See Related
|
NIAAA |
02/14/2018 |
05/16/2018
|
05/08/2021
|
R21/R33
|
Mechanisms of Alcohol Tolerance (R21/R33 Clinical Trial Not Allowed) |
PA-18-619 |
See Related
|
NIAAA |
02/02/2018 |
05/05/2018
|
05/08/2021
|
R01
|
Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R01 - Clinical Trial Optional) |
PA-18-620 |
See Related
|
NIAAA |
02/02/2018 |
05/16/2018
|
05/08/2021
|
R21
|
Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21 - Clinical Trial Optional) |
PA-18-622 |
See Related
|
NINDS |
02/01/2018 |
05/05/2018
|
09/08/2021
|
R01
|
Disease Mechanisms of Prenatal and Pediatric Hydrocephalus (R01 Clinical Trial Not Allowed) |
PA-18-623 |
See Related
|
NINDS |
02/01/2018 |
05/16/2018
|
09/08/2021
|
R21
|
Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus (R21 Clinical Trial Not Allowed) |
PA-18-602 |
See Related
|
NIDA |
01/29/2018 |
05/16/2018
|
05/08/2021
|
R21
|
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21 Clinical Trial Optional) |
PA-18-601 |
See Related
|
NIDA |
01/29/2018 |
05/16/2018
|
05/08/2021
|
R03
|
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03 Clinical Trial Optional) |
PA-18-603 |
See Related
|
NIDA |
01/29/2018 |
05/05/2018
|
05/08/2021
|
R01
|
Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R01 Clinical Trial Optional) |
PAR-18-604 |
See Related
|
FDA |
01/29/2018 |
02/01/2018
|
09/02/2023
|
U18
|
Vet-LIRN Network Capacity-Building Projects |
PA-18-590 |
See Related
|
NIH |
01/26/2018 |
01/26/2018
|
05/31/2021
|
|
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) |
PA-18-592 |
See Related
|
NIH |
01/25/2018 |
01/25/2018
|
09/08/2021
|
|
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed ) |
PA-18-571 |
See Related
|
NIA |
01/11/2018 |
05/16/2018
|
05/08/2021
|
R03
|
Underactive Bladder and Detrusor Activity in Aging (R03 Clinical Trial Optional) |
PA-18-570 |
See Related
|
NIA |
01/11/2018 |
05/05/2018
|
05/08/2021
|
R01
|
Underactive Bladder and Detrusor Activity in Aging (R01 Clinical Trial Optional) |
PA-18-572 |
See Related
|
NIA |
01/11/2018 |
05/16/2018
|
05/08/2021
|
R21
|
Underactive Bladder and Detrusor Activity in Aging (R21 Clinical Trial Optional) |
PAR-18-543 |
See Related
|
NINDS |
12/20/2017 |
01/20/2018
|
05/08/2021
|
U44
|
CREATE Bio Development Track: Preclinical and Early-Phase Clinical Development for Biologics (U44 SBIR- Clinical Trial Optional) |
PAR-18-542 |
See Related
|
NINDS |
12/20/2017 |
01/20/2018
|
05/08/2021
|
U01
|
NINDS CREATE Bio Development Track: Preclinical Development for Biotechnology Products and Biologics (U01 - Clinical Trial Optional) |
PAR-18-506 |
See Related
|
NICHD |
12/18/2017 |
05/05/2018
|
05/08/2021
|
R01
|
Drug Repurposing for Conditions Affecting Neonates and Pregnant Women (R01 - Clinical Trial Optional) |
PAR-18-432 |
See Related
|
NIDCR |
12/15/2017 |
01/12/2018
|
01/08/2022
|
K99/R00
|
NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00-Clinical Trial Required) |
PA-18-499 |
See Related
|
NINR |
12/15/2017 |
05/16/2018
|
05/08/2021
|
R21
|
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R21 Clinical Trial Optional) |
PA-18-498 |
See Related
|
NINR |
12/15/2017 |
05/05/2018
|
05/08/2021
|
R01
|
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R01 Clinical Trial Optional) |
PA-18-493 |
See Related
|
NCI |
12/11/2017 |
05/05/2018
|
05/08/2021
|
R01
|
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional) |
PA-18-492 |
See Related
|
NCI |
12/11/2017 |
05/16/2018
|
05/08/2021
|
R21
|
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional) |
PAS-18-483 |
See Related
|
NINDS |
12/08/2017 |
01/05/2018
|
05/08/2021
|
R01
|
Promoting Research in Basic Neuroscience (R01) |
PA-18-480 |
See Related
|
NICHD |
12/06/2017 |
01/05/2018
|
05/08/2021
|
R01
|
NICHD Research Project Grant (R01 - Clinical Trial Required) |
PA-18-481 |
See Related
|
NICHD |
12/05/2017 |
01/16/2018
|
05/08/2021
|
R03
|
NICHD Small Grant Program (R03 - Clinical Trial Optional) |
PAR-18-468 |
See Related
|
NINDS |
12/04/2017 |
01/12/2018
|
05/08/2021
|
K22
|
NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22) - Clinical Trial Required |
PAR-18-469 |
See Related
|
NINDS |
12/04/2017 |
01/12/2018
|
05/08/2021
|
K22
|
NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22) - Clinical Trial Not Allowed |
PAR-18-420 |
See Related
|
NINDS |
11/29/2017 |
01/05/2018
|
05/08/2021
|
R01
|
NINDS Exploratory Clinical Trials (U01 - Clinical Trials Required) |
PAR-18-422 |
See Related
|
NINDS |
11/29/2017 |
01/05/2018
|
05/08/2021
|
U01
|
NINDS Efficacy Clinical Trials (U01) - Clinical Trial Required |
PAR-18-366 |
See Related
|
NCI |
11/20/2017 |
01/12/2018
|
05/08/2021
|
K22
|
NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials) |
PAR-18-367 |
See Related
|
NCI |
11/20/2017 |
01/12/2018
|
05/08/2021
|
K22
|
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) |
PAR-18-364 |
See Related
|
NCI |
11/17/2017 |
01/12/2018
|
05/08/2021
|
K01
|
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 -Independent Clinical Trial Not Allowed) |
PAR-18-365 |
See Related
|
NCI |
11/17/2017 |
01/12/2018
|
05/08/2021
|
K01
|
NCI Mentored Research Scientist Development Award to Promote Diversity (Parent K01 - Clinical Trial Required) |
PAR-18-360 |
See Related
|
NIDCR |
11/15/2017 |
01/12/2018
|
01/08/2022
|
K22
|
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22-Clinical Trial Required) |
PAR-18-359 |
See Related
|
NIDCR |
11/15/2017 |
01/12/2018
|
01/08/2022
|
K01
|
NIDCR Mentored Career Development Award to Promote Diversity in the Dental, Oral and Craniofacial Research Workforce (K01-Clinical Trial Required) |
PA-18-358 |
See Related
|
NINDS |
11/15/2017 |
01/16/2018
|
05/08/2021
|
R21
|
NINDS Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) |
PAR-18-291 |
See Related
|
NIEHS |
11/08/2017 |
01/13/2018
|
05/08/2021
|
K01
|
Transition to Independent Environmental Health Research (TIEHR) Career Transition Award (K01 Clinical Trial Not Allowed) |
PAR-18-261 |
See Related
|
NIEHS |
11/08/2017 |
01/13/2018
|
05/08/2021
|
K01
|
Transition to Independent Environmental Health Research (TIEHR) Career Transition Award (K01 Clinical Trial Required) |
PA-18-350 |
See Related
|
NIMH |
11/07/2017 |
01/16/2018
|
05/08/2021
|
R21
|
NIMH Exploratory/Developmental Research Grant (R21 - Clinical Trial Not Allowed) |
PA-18-159 |
See Related
|
NINR |
11/07/2017 |
01/17/2018
|
05/08/2021
|
R21
|
Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional) |
PA-18-141 |
See Related
|
NINR |
11/07/2017 |
01/06/2018
|
05/08/2021
|
R01
|
Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional) |
PAR-18-337 |
See Related
|
NCI |
10/31/2017 |
01/12/2018
|
05/08/2021
|
K08
|
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials) |
PAR-18-336 |
See Related
|
NCI |
10/31/2017 |
01/12/2018
|
05/08/2021
|
K08
|
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required) |
PA-18-408 |
See Related
|
NIAMS |
10/26/2017 |
01/16/2018
|
05/08/2021
|
R21
|
Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R21) - Clinical Trial Not Allowed |
PA-18-409 |
See Related
|
NIAMS |
10/26/2017 |
01/05/2018
|
05/08/2021
|
R01
|
Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R01) - Clinical Trial Not Allowed |
PAR-18-324 |
See Related
|
ODP |
10/17/2017 |
01/06/2018
|
05/08/2021
|
R01
|
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional) |
PA-18-322 |
See Related
|
NCCIH |
10/13/2017 |
01/16/2018
|
05/08/2021
|
R21
|
Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional) |
PA-18-323 |
See Related
|
NCCIH |
10/13/2017 |
01/05/2018
|
05/08/2021
|
R01
|
Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional) |
PAR-18-307 |
See Related
|
ODP |
10/10/2017 |
01/17/2018
|
05/08/2021
|
R21/R33
|
Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional) |
PA-17-481 |
See Related
|
AHRQ |
09/12/2017 |
09/12/2017
|
08/09/2022
|
F32
|
Agency for Healthcare Research and Quality (AHRQ)-sponsored National Research Service Award (NRSA)Individual Postdoctoral Fellowship (F32) |
PAR-17-456 |
See Related
|
NINDS |
08/14/2017 |
01/13/2018
|
05/08/2021
|
U01
|
NINDS CREATE Bio Optimization Track for Biologics (U01) |
PAR-17-457 |
See Related
|
NINDS |
08/14/2017 |
01/13/2018
|
05/08/2021
|
U44
|
NINDS CREATE Bio Optimization Track for Biologics (U44) |
PA-17-246 |
See Related
|
AHRQ |
04/03/2017 |
04/17/2017
|
07/17/2021
|
R21
|
Health Information Technology (IT) to Improve Health Care Quality and Outcomes (R21) |
PA-17-232 |
See Related
|
AHRQ |
03/29/2017 |
03/31/2017
|
07/13/2022
|
K08
|
AHRQ Mentored Clinical Scientist Research Career Development Award (K08) |
PA-17-008 |
See Related
|
AHRQ |
10/13/2016 |
01/05/2017
|
07/07/2021
|
R01
|
Large Research Projects for Prevention of Healthcare-Associated Infections (R01) |
PA-16-453 |
See Related
|
AHRQ |
09/29/2016 |
11/02/2016
|
11/02/2021
|
R13
|
AHRQ Conference Grant Programs (R13) |
PA-16-424 |
See Related
|
AHRQ |
09/08/2016 |
01/05/2017
|
02/05/2022
|
R01
|
Developing Measures of Shared Decision Making (R01) |
PA-16-423 |
See Related
|
AHRQ |
09/06/2016 |
11/01/2016
|
10/31/2021
|
R01
|
Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01) |
PA-16-422 |
See Related
|
AHRQ |
09/06/2016 |
11/01/2016
|
10/31/2021
|
R18
|
Large Health Services Research Demonstration and Dissemination Projects for Combating Antibiotic-Resistant Bacteria (CARB)(R18) |